Curriculum Vitae April 2013

NAME Michael Jeffrey Aminoff

CONTACT Box 0114, Room 795-M, Dept of Neurology, 505 Parnassus Ave., San Francisco, CA 94143-0114

Tel: 415 353-1940; Fax 415 353-3289 [email protected]

PLACE OF BIRTH England

NATIONALITY British and US

MARITAL STATUS Married, with three children

CURRENT TITLE Endowed Chair in Parkinson’s Disease Research Distinguished Professor of Neurology & Executive Vice Chair, Department of Neurology, School of Medicine University of California, San Francisco Attending Physician (Neurologist) University of California Medical Center, San Francisco Director, Parkinson's Disease & Movement Disorders Clinic University of California Medical Center, San Francisco

EDUCATION AND TRAINING

EARLY EDUCATION Caterham School, Surrey, England

MEDICAL SCHOOL University College, London, England, 1959-1962 University College Hospital, England, 1962-1965

QUALIFICATIONS 1962 B.Sc. Special (London)

1965 L.R.C.P., M.R.C.S., M.B., B.S. [Equivalent to MD degree in USA]

1968 M.R.C.P. (London) [Similar to Board Certification in Internal Medicine in USA]

1973 M.D. (London) [Advanced Research Thesis similar to Ph.D. in USA]

1976 Federal Licensing Examination and California Medical License

1977 Membership by examination, American Association of Electromyography & Electrodiagnosis, leading in 1989 to Certification by American Board of Electrodiagnostic Medicine.

1980 Certification by the American Board of Clinical Neurophysiology (ABQEEG)

1982 Certification in Neurology, American Board of Psychiatry & Neurology; recertified voluntarily, 2004

1984 F.R.C.P. (London)

1992 Subspecialty certification in Clinical Neurophysiology, American Board of Psychiatry & Neurology (new subspecialty); recertified 2002

1 2000 D.Sc. (London) [Higher doctorate in Faculty of Science, London University, London, UK]

PRINCIPAL POSITIONS HELD

1965-1966 House physician & house surgeon, University College Hospital, London, U.K. 1966-1969 Junior staff member at various London teaching hospitals, London, U.K. 1969-1970 Registrar in Applied Electrophysiology, National Hospital, Queen Square, London, U.K. 1970-1971 Registrar in Neurology, Middlesex Hospital, London, U.K. 1971-1972 Registrar in Neurology, National Hospital, Queen Square, London, U.K. 1972-1976 Senior Registrar, National Hospital for Nervous Diseases, Queen Square & Maida Vale, London, U.K. 1974-1975 Visiting Assistant Professor of Neurology, University of California, San Francisco (on sabbatical) 1976-1982 Associate Professor of Neurology, School of Medicine, University of California, San Francisco 1976-present Attending Neurologist, University of California Medical Center, San Francisco 1976-1996 Attending Neurologist, VA Fort Miley Hospital, and San Francisco General Hospital, San Francisco 1976-2004 Director, Clinical Neurophysiology Laboratories, University of California Medical Center, San Francisco 1982-Present Professor of Neurology, School of Medicine, University of California, San Francisco 1999-Present Consultant Research Physician, Goldman Research Center, UCSF Center on Aging, San Francisco 2004-Present Executive Vice Chair, Department of Neurology, School of Medicine, University of California, San Francisco

PRIZES AND AWARDS (excluding named lectureships & professorships, which are listed separately)

Undergraduate 1961 Honorary B.Sc. Scholarship, University College, London, U.K. 1963 Sir Francis Walshe Prize (Neurology), University College Hospital Medical School, London, U.K. 1964 British Medical Association Student Essay Prize 1965 British Medical Association Student Essay Prize 1965 College of General Practitioners, Undergraduate Essay Prize

Postgraduate 1973 Queen Square Prize for Research in Neurology, Institute of Neurology, London, U.K. 1991 1990 J. Elliott Royer Award for contributions to advancement of neurology. University of California, San Francisco. 2006 Lifetime Achievement Award, American Association of Neuromuscular & Electrodiagnostic Medicine (the highest award by the association to a member) 2007 A. B. Baker Award, American Academy of Neurology, for life-time achievements and contributions to medical education 2010 Honorary member, Gold-Headed Cane Society, University of California, San Francisco 2010 Awarded title of “Distinguished Professor” at University of California, San Francisco

2013 Endowed Chair in Parkinson’s Disease Research at University of California, San Francisco

MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS (Partial listing)

Royal College of Physicians of London (Member) 1968-present (Fellow) 1984-present American Assoc. Electromyography & Electrodiagnosis (Active Member) 1977-present American Academy of Neurology (Associate Member) 1978-1982 (Active Member) 1982-1986 (Fellow) 1986-present American EEG/Clinical Neurophysiology Soc. (Active Member/Fellow) 1978-2010 American Epilepsy Society (Active Member) 1978-1998 San Francisco Neurological Society (Active Member) 1979-present American Neurological Association (Active Member) 1981-present American Academy of Clinical Neurophysiology (Member) 1985-1998 Association of British Neurologists (Overseas Member) 1995-present Council of Science Editors [member] 1998-2005 World Association of Medical Editors [member] 1998-2007 Movement Disorders Society [member] 2000-present

Honorary Memberships

Canadian Society of Clinical Neurophysiologists (Honorary Member) 1996-present French Neurological Society (Honorary Foreign Member) 2008-present UCSF Gold-Headed Cane Society (Honorary member) 2010-present

ACTIVITIES FOR PROFESSIONAL ORGANIZATIONS AND PUBLICATIONS

UCSF 1979-present Director, Parkinson's Disease & Movement Disorders Clinic; UCSF (designated a Center of Excellence affiliated with the National Parkinson Foundation since 1992)

American Academy of Neurology 1989-1997 Editorial Board, Neurology 1992-1994 Vice Chair, Section of Clinical Neurophysiology (newly-created in 1992) 1993-1996 Member, Scientific Program Subcommittee of the Scientific Issues Committee and Topic Chair for Clinical Neurophysiology 1994-1996 Chairman, Section of Clinical Neurophysiology 1994-1999 Member, Animal Studies Subcommittee 1994-1996 Member, Committee on Sections 1997 Director, EMG Course at annual meeting 1998 Director, Advanced EMG course at annual meeting 1999-2000 Member, Scientific Program Subcommittee of the Scientific Issues Committee and topic chair for Neurologic Manifestation of Systemic Diseases 2001-2003 Director, Course on Neurologic Manifestations of Systemic Diseases at annual meeting 2001-2006 Member, Publications Committee (Vice Chair, 2003–6)

American Association of Neuromuscular and Electrodiagnostic Medicine (formerly of Electromyography and Electrodiagnosis) 1979-80 Member, Constitution Committee 1980-1983 Member, Education Committee 1983-1984 Member, Scientific Program Committee 1984-1985 Member, Course Committee

3 1987-1989 Member, Constitution Committee 1988-2000 Official liaison with American Neurological Association 1989-1990 Chairman, Scientific Program Committee 1993-1994 Member, Finance Committee 2000-2002 Member, Core Curriculum Task Force.

Western EEG Society 1984-1987 Member, Board of Directors,

American Academy of Clinical Neurophysiology 1985-present Member, Executive Committee 1987-1989 Treasurer 1987-1991 Chairman, Public Relations & Membership Committee 1987-1989 Member, Long Range Planning Committee 1989-1991 President-Elect 1991-1993 President 1993-1995 Member of Executive Council and Chair of Nomination Committee 1995-1997 Member, Scientific Program Committee

American Clinical Neurophysiology Society (formerly American EEG Society) 1987-1988 Chairman, Scientific Program Committee 1987-1989 Member, Committee on Evoked Potentials 1989-1994 Member, Board of Laboratory Accreditation 1988-1989 Chairman, Committee on Evoked Potentials 1989-1992 Member, Long Range Planning Committee 1989-1992 Member of Council 1990-1994 Co-chairman, Board of Laboratory Accreditation 1992-1993 Member, Scientific Program Committee 1992-2000 Member, Journal Oversight Committee (Chair, 1995-1996) 1993-1997 Member, Long Range Planning Committee 1993-1997 Alternate delegate, International Federation of Societies for Clinical Neurophysiology 1993-1994 Vice-president and President-Elect 1994-1995 President 1995-1997 Member of Council 1996-1997 Chairman, Nominating Committee 1997-1998 Member, Committee on Principle of Laboratory Accreditation 2000-2005 Member, Awards Committee

California Medical Association 1988-1993 Member, Scientific Advisory Panel on Neurology 2001 Member, Neurology Scientific Committee, CMA Council of Scientific Affairs

American Epilepsy Society 1992-1994 Member, Long Range Planning Committee 1992-1994 Chair, Journal Committee

World Federation of Neurology: Research Group on the Autonomic Nervous System 1993-1997 Secretary

Parkinson’s Study Group 1997- Co-investigator in various studies 1997-98 Member of steering committee for a study of deep brain stimulation in patients with Parkinson’s disease

Association of California Neurologists, 1998-2001 Board of Directors

American Neurological Association 1997-1999 Member, Honorary Membership Advisory Committee

4 2000-2003 Member, History of the Association Committee 2005-2007 Member, Journal Oversight Committee 2006-2008 Member, Membership Committee

Referee for Journals In last 10 years, in addition to reviewing papers for journals on whose editorial board I serve, I have acted as ad hoc referee for: Annals of Neurology Archives of Neurology Annals of Internal Medicine Brain Research Clinical Neurophysiology Neurology Archives of Internal Medicine Journal of the Neurological Sciences New England Journal of Medicine Journal of Neurology, Neurosurgery, and Psychiatry Journal of Clinical Neurophysiology

Editorial Boards of Journals 1987-1991 (5 y): Clinical Evoked Potentials 1988-1992 (5 y): Epilepsy Advances 1989-1997 (9 y): Neurology 1989-2001 (13 y): Electroencephalography & Clinical Neurophysiology 1990-1993 (4 y): Muscle & Nerve 1990-2006 (7 y): Journal of Clinical Neurophysiology 1993-1995 (3 y) Internal Medicine Bulletin 1994-1997 (4 y): Journal of Neurology, Neurosurgery & Psychiatry 1994-present Clinical Neurology & Neurosurgery 1996-present Clinical Autonomic Research 1996-2004 (9 y): Neurobase (electronic journal) 1996-2002 (7 y) Associate Editor, Neurology Network Commentary/ Lancet-Neurology Network 2001-present Expert Review of Neurotherapeutics 2004-present Editor-in-Chief, neurology section, UptoDate 2007-present Drugs of Today

Editor-in-Chief 1998-2007 (10 y) Muscle & Nerve

Certifying Bodies 1. 1989-1996 (8 yrs) Board Member, American Board of Clinical Neurophysiology 1990-1996 Chairman, American Board of Clinical Neurophysiology (ABCN) Member, Examination Committee, ABCN

2. 1990-1996 Board Member, American Board of Electrodiagnostic Medicine (ABEM) Member, Examination Committee, ABEM 1992-1994 Member, Nominating Committee, ABEM 1993-1997 Member, Long Range Planning Committee, ABEM (Chair, 1996-7) 1993-1994 Treasurer, American Board of Electrodiagnostic Medicine 1994-1996 Chairman, American Board of Electrodiagnostic Medicine 1994-1996 Member, Appeals Panel, ABEM

3. 1998-2011 Member, Committees on Certification and Recertification for Added Qualifications in Clinical Neurophysiology, American Board of Psychiatry & Neurology 2004-2011 (8 yrs) Member, Board of Directors, American Board of Psychiatry & Neurology

5 Chair, Committee of Subspecialty Recertification (MOC) in Clinical Neurophysiology Member Clinical Neurophysiology Steering Committee (chair, 2005- ) Member, Committee on Bye-Laws (chair 2010- Member, Part I Examination Committee in Neurology Member, Part II Examination Committee in Neurology Member, Committee on Maintenance of Certification (Recertification) in Neurology (co-chair, 2005- ) Member, Strategic Planning Committee Member, Committee on Core Competencies (chair, 2008-) ABPN Delegate to the American Board of Medical Specialties (chair, 2006- ) Member, Committee on Finance Chair, Committee on Core Competencies 2008-2011 Chair, Committee to Review Appeals in Neurology Committee on Research & Development (Neurology) 2009-2011 Member, Executive Committee 2010 Board Secretary 2011 Chair of the Board

4. 2004-2011 (8 yrs) ABPN Delegate, American Board of Medical Specialties (ABMS) 2005-2007 Member, ABMS Initial Certification Task Force 2007-2010 Member, ABMS Governance Committee

Review Work (other than for funding agencies)

1995-1996: Committee member, Institute of Medicine/National Academy of Sciences Committee to review the health effects in Vietnam Veterans of exposure to herbicides (First Biennial Update.) 1996-2011: Consultant, Neurological Devices Panel, Food & Drug Administration 1997-1998 Committee member, Institute of Medicine/National Academy of Sciences Committee to review the health effects in Vietnam Veterans of exposure to herbicides (Second Biennial Update.) 1999 Committee member, Institute of Medicine's Committee to review the evidence regarding link between exposure to Agent Orange and Diabetes

ADMINISTRATIVE EXPERIENCE

As Director of the UCSF Clinical Neurophysiology Laboratory for 28 years, I was responsible for the administration of a unit involving between 8 and 10 associated physicians, and 6-8 clerical/technological staff members. This appointment involved regularly dealing with the hospital administrative system, preparation of budgets, dealing with reimbursement issues, and even-handed balancing of the interests of the laboratory to avoid internal conflicts or conflicts between the interests of the hospital and the School of Medicine. Since 2004, I have served as executive vice chair of the department of neurology, with primary responsibility for academic affairs. This includes the development and supervision of a departmental mentoring process for residents and faculty, and – in conjunction with the chair -- assisting the promotion process (and preparation of dossiers to be filed in the dean’s office) within the department, review of faculty, nomination for national awards and prizes, etc.

RESEARCH INTERESTS

My research has been of both the “pure” and “applied” variety. Pure or basic research has been undertaken both in animals (until 1976) and in humans, and has been aimed at extending understanding about the function of the nervous system and about disease-concepts. Such studies are exemplified by Publication Nos. 2, 19, 27, 28, 29, 33, 61, 96 on the autonomic nervous system and Nos. 55, 64, 73, 79, 86, 88, 95, 101, 109, 110, 121, 122, 125, 130-132, 138, 142, dealing with motor control or the cerebral processing of sensory information.

6 Clinical research - to better characterize disease processes or analyze clinical phenomena - has been directed at several different areas but particularly at arteriovenous malformations (e.g. Publ. Nos. 12, 13, 16, 17, 21, 23, 74, 82, 91), the autonomic nervous system (e.g. Publ. Nos. 4, 18, 38, 39, 61, 71, 96, 103, 107, 147), movement disorders (e.g. Publ. Nos. 4, 6, 11, 14, 15, 20, 25-27, 35, 46, 49, 54, 80, 81, 89, 100, 102, 105, 119, 124), and the application of electrophysiologic techniques to clinical disorders of the peripheral or central nervous systems (e.g. Publ. Nos. 40-42, 47, 50, 60, 62, 63, 65, 66-70, 75-77, 85, 92-94, 97-101, 108, 111-115, 118, 120, 123, 136, 145, 149). ). My most recent interests have been in the area of translational research, bringing advances from the basic laboratories into a clinical setting, especially with regard to the treatment of Parkinson’s disease.

EDUCATIONAL ACTIVITIES

In addition to my departmental clinical teaching load, I devote considerable time to the teaching of clinical neurophysiology to our residents and other junior staff, and encourage the use of neurophysiological approaches to the investigation of neurological disorders. As Chairman of the American Board of Clinical Neurophysiology, I was concerned with syllabus development and the examination for competence in this field of candidates on a national level. Further, as a member (and chairman] of the American Board of Electrodiagnostic Medicine I was involved in setting national guidelines and standards, and assessing competence, in the clinical and electrodiagnostic aspects of neuromuscular disorders. I continue this educational activity in neurology and clinical neurophysiology as a director of the American Board of Psychiatry & Neurology. In addition, I lecture frequently at regional, national and international meetings, have authored or co-authored five books and edited ten others, some of which have gone into several editions. I have contributed numerous chapters to the books of other authors. I am editor-in-chief (with R. B Daroff) of a multivolume Encyclopedia of the Neurological Sciences, published in 2003, and in 2003 was appointed one of the series editors of the Handbook of Clinical Neurology.

I am currently responsible for organizing the mentoring activities of the department with respect to both resident staff and junior faculty. I have been responsible for selecting and communicating with mentors and mentees and for dealing with a variety of problems as the mentoring program of the department evolves and expands. This includes developing guidelines for mentors and objectives for the program.

I received the A.B. Baker Award of the American Academy of Neurology in 2007 for lifetime achievement and contributions to medical education.

SCIENTIFIC & PROFESSIONAL MEETINGS ATTENDED SINCE 1976

International 12th Epilepsy International Symposium 1980 (paper) 14th Epilepsy International Symposium 1982 (2 papers) 2nd International Evoked Potential Symposium 1982 (paper) International Somatosensory Evoked Potential Symposium 1984 (2 papers) 11th International Congress of EEG and Clinical Neurophysiology 1985 (4 papers: chairman in workship session) 3rd International Evoked Potential Symposium 1986 (4 papers) 8th International Congress of Electromyography & Related Clinical Neurophysiology 1987 (lecture; demonstration; chairman of talking poster session) 9th International Symposium on Parkinson's Disease 1988 (lecture & paper) 12th International Congress of EEG and Clinical Neurophysiology 1990 (lecture; 2 papers; chairman of poster session) 13th International Congress of Clinical Neurophysiology 1993 (workshop; video demonstration; chairman of poster session) 1st International Congress on the History of the Neurosciences, 1994 (Symposium chair; lecture). International Symposium on Dementia in Parkinson's Disease, 1994 (lecture) 10th International Congress of EMG and Clinical Neurophysiology 1995 (lecture; workshop chair) 14th International Congress of EEG and Clinical Neurophysiology 1997 (workshop lecture and chair) 6th International Congress of Parkinson's Disease and Movement Disorders, 2000 (2 papers) 15th International Congress of Clinical Neurophysiology, 2001 (lecture)

7 Combined International Congress of Clinical Neurophysiology and annual meetings of the American Association of Electromyography & Electrodiagnosis and the American Clinical Neurophysiology Society, 2003 (lecture and 2 seminars) 11th Panamerican Congress of Neurology and 58th Chilean Congress of Neurology, Psychiatry, & Neurosurgery, 2003 (2 lectures) 18th International Congress of Clinical Neurophysiology/ Mexican Society of Clinical Neurophysiology, Veracruz, Mexico, 2004 (3 lectures) 23rd annual J.L. Silversides Visiting Professor of Neurology, University of Toronto, Toronto, Canada (3 lectures) 40th Turkish National Congress of Neurology, Antalya, Turkey, 2004 (2 lectures) 11th Biennial Clinical Neurophysiology Workshop, Australian Association of Neurologists, Australia, 2005 (2 lectures, and leader of discussion of scientific papers] 19th International Congress of Clinical Neurophysiology/ Mexican Society of Clinical Neurophysiology, Oaxaca, Mexico, 2006 (4 lectures) International Commission on Occupational Health, International Satellite Course on Neurotoxicants and Neurodegenerative Disorders, Venice, Italy (2 lectures) 28th International Congress of Clinical Neurophysiology, Edinburgh, UK (lecture; seminar) 11th International Congress of Parkinson's Disease and Movement Disorders, Istanbul, Turkey 2007 (paper) Taiwan Neurological Society, annual meeting, Taipei, Taiwan, 2007 (plenary lecture) 13th International Congress of Parkinson's Disease and Movement Disorders, Paris, France 2009 (paper)

National American Academy of Neurology 1977, 1979 (paper), 1980 (lecture & paper), 1983 (lecture), 1985 (lecture), 1986 (3 lectures, 6 papers, co-chairman of scientific session), 1987 (3 lectures, 3 papers), 1988 (workshop, 2 papers); 1989 (workshop, 6 papers); 1990 (lecture, 3 papers); 1991 (lecture; seminar; paper); 1992 (3 lectures, 1 seminar); 1993 (workshop, seminar, 2 papers); 1994 (seminar, paper); 1995 (paper); 1996 (2 lectures, 5 papers); 1997 (2 lectures; course chair); 1998 (2 lectures, 2 papers); 1999 (lecture); 2000 (lecture); 2001 (lecture; course director); 2002 (lecture; course director); 2003 (lecture; course director); 2004; 2007 (lecture; A.B.Baker Award); 2009 American Society for Pharmacology & Experimental Therapeutics 1977 (paper) American Neurological Association 1981, 1982 (4 papers), 1983 (paper), 1986 (paper), 1987 (2 papers); 1990; 1991; 1994; 1998; 1999; 2001; 2003 American EEG Society 1981 (paper), 1982 (lecture), 1983 (3 papers), 1987 (lecture, 2 papers), 1988 (paper, chairman of 2 symposia); 1989 (paper); 1990; 1992 (lecture); 1993 (lecture, paper); 1994 (paper); 1995 (2 papers); 1996 (2 papers); 1997; 2002 (paper); 2003(lecture; 2 seminars) American Association of Electrodiagnostic Medicine (formerly American Association for Electromyography and Electrodiagnosis) 1977, 1981 (lecture), 1983 (2 seminars), 1984 (lecture & 2 seminars), 1988 (paper), 1989 (lecture and 2 papers); 1990 (lecture; chairman of didactic session and scientific session); 1991 (seminar); 1992 (seminar); 1993 (lecture); 1994 (seminar); 1995 (seminar); 1996 (seminar); 1997; 1998; 1999; 2000; 2001; 2002 (seminar); 2003 (lecture; 2 seminars); 2006 (Lifetime Achievement Award); 2007; 2011 American Association of Neurological Surgeons 1984 (seminar) Congress of Neurological Surgeons 1985 (2 lectures) American Academy of Clinical Neurophysiology 1986 (2 papers, lecture, chairman of one session), 1987 (paper, lecture, chairman of one session), 1988 (lecture, chairman of one session), 1989 (lecture, seminar), 1990 (seminar); 1991 (lecture); 1992 (lecture, 3 papers); 1993 (2 papers); 1994; 1995; 1996 (chair of session) Canadian Congress of Neurological Sciences 1987 (lecture); 1996 (official guest; 2 lectures) American Society for Clinical Evoked Potentials 1989 (lecture); 1990 (lecture)

Regional American Federation for Clinical Research (Western Section) 1979 (paper) Western EEG Society 1981 (lecture), 1982 (lecture), 1983 (2 papers), 1985 (lecture)

UNIVERSITY SERVICE

8 Service on ad hoc review committees for the academic peer review process in 1979, 1980 (as chairman), 1981 (chairman), 1982 (twice; once as chairman), 1983, 1984, 1986 (chairman), 1988, 1989 (chairman), 1990 (chairman); 1991; 1992 (chair); 1993 (chair); 1994 (twice; once as chair); 1995 (twice; once as chair); 1996 (chairman); 1998; 1999 (three times); 2000; 2001 Member (for Department of Neurology) of the Representative Assembly of the Academic Senate, 1980-82 Member, Senate Library Committee, 1982-1984 Member, Clinical Clerkship Operations Subcommittee, 1983-1985, 1988 Member, Alpha Omega Alpha Selection Committee, 1988 Member, Credentials Committee of the Medical Staff, UCSF Medical Center, 1990-1994 Member, Advisory Committee on Instructional & Research Support Services, 1992-1996 Chair, Ad Hoc committee to investigate allegations of misconduct by a faculty member, 1998-1999 Chair, Stewardship Committee, 2000-2001 Member, Committee on Human Research, 2001-2003 Member, Privilege and Tenure Committee, 2001-2004 Member, UCSF Senate Task Force on Interim Procedure for Investigation of Faculty Misconduct, 2002 Chair, Stewardship Committee, 2004-2005 Chair, Ad Hoc committee to investigate allegations of misconduct by a faculty member, 2010

DEPARTMENTAL COMMITTEES

Search Committees

For clinical electromyographer (1981 and 1985), Epilepsy Program director (1985), pediatric neurologist (1989), Director of UCSF/Mt. Zion Sleep Disorders Center (1991), neurointensivist (1993), epileptologist (1993), electromyographer and clinical neurologist (1993), Director of Clinical Neurology at San Francisco General Hospital (1994), neurorehabilitation specialist at UCSF/Mt. Zion (1994), neurorehabilitation specialist at VA Medical Center (1995), behavioral neurologist (1997), specialist in movement disorders (1998), neurologist/neuroscientist to hold the Aird Chair (1999), Director of MS Clinic (2000), Betty Anker Fife Chair in Neurology (2001), Gallo Family Chair in Neurology (2004); three faculty positions [2010]; two faculty positions [2011]; Franceschi & Mitchell Endowed Neurohospitalist Chair (2012); Cahill Endowed Chair in Parkinson’s Disease Research (2012)

Selection Committees

1976-1992 ad hoc interviewer of resident applicants 1992-1993 Member, Resident Selection Committee 1996-1997 Member, Resident Selection Committee 1985-2004 Member, Selection Committee for Neuromuscular Fellowship Program 1994-2004 Member, Selection Committee for Clinical Neurophysiology/Epilepsy Fellowship Program 2000-2001 Member, Resident Selection Committee 2004-2005 Member, Resident Selection Committee

Other

1976-present Service on ad hoc review committees of the Department of Neurology to assess the progress of junior faculty and to review candidates for promotion or tenure. 1994-present Clinical Practice Committee, Department of Neurology 1993-present Appointments and Promotions Committee, Department of Neurology [chair, 2010-] 1993-present Executive Committee, Department of Neurology

CLINICAL SERVICE (2011-2012)

Outpatient work 8 hours/week Attending Physician, Neurology Service, (approx. 160 hrs/year) 3 hours/week Total: 11 hours/week

TEACHING DUTIES IN PRESENT APPOINTMENT

Regular Teaching Duties 2011-2012

Neurology 453 course: Instruction in Clinical Neurophysiology Seminars with neurology housestaff doing clinical neurophysiology (formal seminar) 60 hours/year Neurology resident teaching in Movement Disorders Clinic and on Consult or ward Service 230 hours/year Neurology 140.09 course: Consult or ward Attending with students 80 hours/year Total 370 hours/year

Total Time for Regular Teaching Duties

2008-2009 430 teaching hours, including 40-hours’ preparation 2009-2010 430 teaching hours, as above 2010-2011 410 teaching hours, as above 2011-2012 anticipated 410 teaching hours, as above

Course and Lecture Preparation

Time spent in preparing material for courses and lectures is approximately 40 hours/year.

Teaching Awards

1991 Outstanding Teacher Award by the Resident Staff, Department of Neurology, UCSF 2007 A.B. Baker Award of the American Academy of Neurology for lifetime achievement in medical education

Mentoring activities

1. I serve as the formal departmental mentor for one resident and two junior faculty, meeting with them at least twice annually and additionally as needed. (I am currently mentoring Asst Profs. Bruce Cree and Nerissa Ko, and resident Sarah Shalev.) I mentor many other junior faculty and residents on an informal, ad hoc basis.

2. I serve as the mentor facilitator for the department, being responsible for organizing the mentoring of both resident staff and junior faculty. I select and communicate with mentors and mentees and have had to deal with a variety of problems as the mentoring program of the department has developed. This includes developing guidelines for mentors and objectives for the program, and interacting with the Dean’s office

Tine spent in mentoring activities: 150 hours per year

Additional Teaching in Recent Years

I have lectured extensively in all parts of the United States, giving between 10 and 12 lectures annually to other departments at UCSF and at university and community hospitals, regional neurological societies, and at national and international meetings. I have given lectures at courses sponsored by the American Academy of Neurology, the American Academy of Clinical Neurophysiology, the American EEG Society, the American Association of Electrodiagnostic Medicine, the American Academy of Occupational Medicine, the American College of Surgeons, and the Canadian Congress

10 of Neurological Sciences and at courses sponsored by numerous medical schools in the United States and overseas.

The following partial listing is noteworthy: 1987: Invited lecturer at combined meeting of Finnish Society of Neurology and the Finnish Society of Clinical Neurophysiology, Kuopio, Finland Visiting Professor of Clinical Neurophysiology, Mayo Clinic, Rochester, Minnesota 1988: Visiting Professor of Neurology, Loyola University Stritch School of Medicine, Chicago Visiting Professor of Neurology, Vanderbilt University, Nashville, Tennessee Invited speaker, 9th International Symposium on Parkinson's Disease, Jerusalem, Israel 1989: Visiting Professor of Medicine, University of Hawaii, Honolulu, Hawaii (in residence for 1 week) 1990: Invited speaker, 12th International Congress on EEG and Clinical Neurophysiology, Rio de Janeiro, Brazil 1991: Jerome K. Merlis Lecturer in Neuroscience, University of Maryland, Baltimore 1992: Visiting Professor of Neurology, Loyola University Stritch School of Medicine, Chicago Visiting Professor of Neurology, Hahnemann University, Philadelphia Jesse Barber Oration Lecturer, at annual meeting of National Medical Association, San Francisco 1993: Visiting Professor of Neurology, University of Western Ontario, Canada Invited speaker, 13th International Congress of Clinical Neurophysiology, Vancouver, Canada 1994: Invited speaker, International Symposium on Dementia in Parkinson's Disease, Jerusalem, Israel Invited speaker and workshop coordinator, lst International Congress on the History of the Neurosciences, London, England 1995: Visiting Professor of Neurology, University of Michigan, Ann Arbor Invited speaker, International Congress of EMG and Clinical Neurophysiology, Kyoto, Japan 1996: Guy Williams Lecturer, Cleveland Clinic Foundation, Cleveland, Ohio Official Guest and Lecturer, Canadian Society of Clinical Neurophysiologists, at the Canadian Congress of Neurological Sciences 1997: Invited speaker and workshop chair, 14th International Congress of EEG and Clinical Neurophysiology, Florence, Italy Chopra Oration Lecturer, Indian Academy of Neurology, and Director of 6th International Workshop on Clinical Neurophysiology, Madras, India Visiting Professor of Neurology, University of Virginia, Richmond, Virginia Invited Speaker, 15th Brazilian Congress of Clinical Neurophysiology, Curitiba, Brazil 1998: A.B. Baker Lecture, University of Minnesota, Department of Neurology, Minneapolis Invited lecturer, 6th International Conference on Computer and Quantitative EMG, Vigo, Spain Invited lecturer, course on advances in neurology, Bombay, India (4 lectures and workshop) Invited lecturer, 8th Biennial Clinical Neurophysiology Workshop, Australian Association of Neurologists, Australia 2000: Invited lecturer, Brazilian Academy of Neurology, Salvador, Bahia, Brazil 2001: Invited lecturer, Brazilian Congress of Clinical Neurophysiology, Recife, Brazil (3 lectures) 2001: Invited lecturer, 3rd International Course on Electrodiagnosis, National Rehabilitation Center, Mexico City, Mexico (3 lectures and demonstration) 2001: Invited lecturer, World Congress of Neurology, London, England 2002: Invited speaker, 10th International Congress on Neuromuscular Disease, Vancouver, Canada (Meet-the-Professor: Autonomic disorders and neuromuscular disease). 2003: Invited speaker: Combined International Congress of Clinical Neurophysiology and annual meetings of the American Association of Electromyography & Electrodiagnosis and the American Clinical Neurophysiology Society, San Francisco (lecture and 2 seminars) Invited lecturer: 11th Pan-American Congress of Neurology and 58th Chilean Congress of Neurology, Psychiatry, & Neurosurgery, Santiago, Chile (2 lectures) 2004: Invited Guest, 18th International Congress of Clinical Neurophysiology/ Mexican Society of Clinical Neurophysiology, Veracruz, Mexico (3 lectures) 23rd annual J.L. Silversides Visiting Professor of Neurology, University of Toronto, Toronto, Canada (3 lectures) Invited lecturer, 40th Turkish National Congress of Neurology, Antalya, Turkey (2 lectures) 2005: Invited lecturer, 11th Biennial Clinical Neurophysiology Workshop, Australian Association of Neurologists, Australia (2 lectures, and leader of discussion of scientific papers) 2006: Invited lecturer, 19th International Congress of Clinical Neurophysiology/ Mexican Society of

11 Clinical Neurophysiology, Oaxaca, Mexico, 2006 (4 lectures) Invited lecturer, International Commission on Occupational Health, International Satellite Course on Neurotoxicants and Neurodegenerative Disorders, Venice, Italy (2 lectures) Invited lecturer, 28th International Congress of Clinical Neurophysiology , Edinburgh, UK (lecture; seminar) 2007: Invited plenary lecturer at the annual meeting of the Taiwan Neurological Society, Taipei, Taiwan A.B.Baker Award lecture, annual meeting, American Academy of Neurology, Boston, Mass. 2nd Romeo Gustilo Memorial Lecture Series lecturer, Manila, The Philippines (1 lecture) Invited lecturer at the Philippines Neurological Association bimonthly scientific conference (1 lecture) 2008: Invited lecturer, Cleveland Clinic, Cleveland, Ohio (two lectures) Invited Professor, 40th anniversary celebrations of the Mexican Society of Clinical Neurophysiology, Mexico City, Mexico (two lectures) 2009: Invited lecturer, 33rd Congress of Clinical Electromyography Society and 7th International Congress of Pediatric EMG, Ajaccio, Corsica, France Donald Baxter Lecturer, Montreal Neurological Institute, Montreal, Canada 2012: Visiting Professor of Neurology and Grand Rounds speaker, University of Pittsburg, Pittsburg, Pennsylvania. Visiting Professor of Neurology and Grand Rounds speaker, University of Maryland, Baltimore, Maryland

Television Programs

2011

“PD: A Dose of Hope”. Program on Parkinson’s disease for patients and caregivers produced by UCTV and aired nationally for 1 week. Continues to be available on websites for UCTV, YouTube, and the UCSF PD Center. “PD: Latest from the Experts.” Program on Parkinson’s disease for health-care professionals produced by UCTV and aired nationally for 1 week. Continues to be available on websites for UCTV, YouTube, and the UCSF PD Center.

FELLOWS AND OTHER POSTGRADUATE TRAINEES

I have been responsible for the further training of the following persons:

Clinical neurophysiology

Alfred L. Ochs (USA) Douglas S. Goodin (USA) William Marks (USA) John R. Cutler (USA) Richard McCarthy (USA) John W. Hill (New Zealand) Yasar Kutukcu (Turkey) Joseph Cimino (USA) David Leppert (Switzerland) Sandra L. Shefrin (USA) Dan-Lin Min (China) Rosalind Hill (New Zealand) Steven Chung (USA) Ina Tarkka (Finland) Cathy Lomen-Hoerth (USA) Pang-Ying Shih (Taiwan) Lisa Bateman (Canada) Ricardo C. Reisin (Argentina) Oliver Bernath (UK) Marta Elian (England) Bassam Assaf (USA) John W. Engstrom (USA) James Wei (USA) Rosemary Santos Chequer (Brazil) Taoufik Al Saadi (USA) Tomas Ortiz (Spain) Kameel Karkar (USA) Paul Garcia (USA) Tammy Tsuchida (USA)

12 Conception Maeztu (Spain) Timothy Miller (USA) Robert Knowlton (USA) Jeffrey Ralph (USA) Jack Parent (USA) Kitti Kaiboriboon (USA)

In addition, I was the Director of the ACGME-accredited Fellowship Program in Clinical Neurophysiology sponsored by the Department of Neurology at UCSF from its inception until 2004, when I stepped down. There are two fellows annually: one in EMG/neuromuscular Diseases and the other in EEG/Epilepsy.

Movement disorders

I have been responsible for the training in movement disorders, at least in part, of many of the fellows who have been here at UCSF and of several of our junior faculty. They are not listed individually as I have not been their program director.

RESEARCH SUPPORT (only current support is shown)

Avigen Inc./Genzyme Inc 7/1/04-15 $2,088,353 Protocol AAV-hAADC-2-003 A phase I open-label safety study of intrastriatal infusion of adeno-associated virus encoding human aromatic L-amino acid decarboxylase in subjects with advanced Parkinson’s disease. PI: Aminoff

National Institutes of Health 1U10NS044460-01 to -06 NINDS “Parkinson’s Disease Neuroprotection Clinical Trial”. Project Number (site PI, Aminoff) 9/1/02- 1/31/08 (direct costs) $265,797 2/1/08-11/30/09 (direct costs) $139,378 ongoing The major goal of this project is to conduct multicenter studies of the efficacy of neuroprotective agents in Parkinson’s Disease.

Mount Zion Health Fund (PI: Aminoff) 8/1/10-7/31-11 $20,000 To support outreach program

Kinemed Inc. Cerebrospinal fluid biomarkers of microtubule-mediated axonal transport for monitoring of disease progression and therapeutic interventions in Parkinson’s disease 3/1/10-2/28/11 $15,681

Kinetics Foundation Assessment of objective measures of motor impairment in Parkinson's disease: Evaluation of a computer-based system. 4/1/09-3/31/11 $20,992

Teva Educational Grant To support a patient & caregiver Conference on Parkinson’s Disease 2009 $12,000 2010 $15,000 2011 $24,700

PUBLISHED PAPERS (Abstracts and letters are listed separately)

1. AMINOFF MJ: An experiment in medical education. Br J Hosp Med 3:857-858, 1970

2. AMINOFF MJ, Sears TA: Spinal integration of segmental, cortical and breathing inputs to thoracic respiratory motoneurons. J Physiol (Lond) 215:557-573, 1971

3. AMINOFF MJ: Dystrophia myotonica presenting with dysphagia. Br Med J 2:443, 1971

4. AMINOFF MJ, Wilcox CS: Assessment of autonomic function in patients with a parkinsonian syndrome. Br Med J 4:80-84, 1971

5. AMINOFF MJ, Wilcox CS: Autonomic dysfunction in syringomyelia. Postgrad Med J 48:113-115, 1972

6. AMINOFF MJ: Acanthocytosis and neurological disease. Brain 95:749-760, 1972

7. Lantos PL, AMINOFF MJ: Ultrastructural changes in sural nerve biopsies in patients with acanthocytosis. Acta Neuropathol (Berl) 22:257-263, 1972

8. AMINOFF MJ: The plasticity of the cutaneous abdominal reflex. M.D. Thesis: University of London, 1972

9. AMINOFF MJ, Miller AL: The prevalence of diabetes mellitus in patients with Bell's palsy. Acta Neurol Scand 48:381-384, 1972

10. AMINOFF MJ: Bell's palsy and its treatment. Postgrad Med J 49:46-51, 1973

11. AMINOFF MJ, Wilcox CS, Woakes MM, Kremer M: Levodopa therapy for Parkinsonism in the Shy-Drager syndrome. J Neurol Neursurg Psychiatry 36:350-353, 1973

12. AMINOFF MJ: Vascular anomalies in the intracranial dura mater. Brain 96:601-612, 1973

13. AMINOFF MJ, Kendall BE: Asymptomatic dural vascular anomalies. Br J Radiol 46:662-667, 1973

14. AMINOFF MJ, Gross M: Vasoregulatory activity in patients with Huntington's chorea. J Neurol Sci 21:33-38, 1974

15. AMINOFF MJ, Marshall J: Treatment of Huntington's chorea with lithium carbonate. Lancet 1:107-109, 1974.

16. AMINOFF MJ, Logue V: Clinical features of spinal vascular malformations. Brain 97:197-210, 1974

17. AMINOFF MJ, Logue V: The prognosis of patients with spinal vascular malformations. Brain 97:211-218, 1974

18. Wilcox CS, AMINOFF MJ, Penn W: Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 37:677-684, 1974 14

19. Wilcox CS, AMINOFF MJ, Kurtz AB, Slater JDH: Comparison of the renin response to dopamine and noradrenaline in normal subjects and patients with autonomic insufficiency. Clin Sci 46:481-488, 1974 20. AMINOFF MJ, Trenchard A, Turner P, Wood WG, Hills M: Plasma uptake of dopamine and 5-hydroxytryptamine, and plasma catecholamine levels in patients with Huntington's chorea. Lancet 2:1115-1116, 1974

21. AMINOFF MJ, Barnard RO, Logue V: The pathophysiology of spinal vascular malformations. J Neurol Sci 23:255-263, 1974

22. AMINOFF MJ: Clinical aspects of Bell's palsy. Br J Hosp Med 12:559-568, 1974

23. Logue V, AMINOFF MJ, Kendall BE: The results of surgical treatment for patients with a spinal angioma. J Neurol Neurosurg Psychiatry 37:1074-1081, 1974

24. Wilcox CS, AMINOFF MJ, Millar JGB, Keenan J, Kremer M: Circulating levels of corticotrophin and cortisol after infusions of L-dopa, dopamine and noradrenaline in man. Clin Endocrinol 4:191-198, 1975

25. AMINOFF MJ, Gross M, Laatz B, Vakil SD, Petrie A, Calne DB: The arterial pressure in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 38:73-77, 1975

26. AMINOFF MJ, Marshall J, Smith EM, Wyke M: The pattern of intellectual impairment in Huntington's chorea. Psychol Med 5:169-172, 1975

27. Wilcox CS, AMINOFF MJ: Blood pressure responses to dopamine and noradrenaline infusions in Parkinson's disease and the Shy-Drager syndrome. Br J Clin Pharmacol 3:207-214, 1976

28. Sampson SR, AMINOFF MJ, Jaffe RA, Vidruk EH: Analysis of the inhibitory effect of dopamine on carotid body chemoreceptors in cats. Am J Physiol 230:1494-1498, 1976

29. Sampson SR, AMINOFF MJ, Jaffe RA, Vidruk EH: Pharmacological analysis of neurally induced inhibition of carotid body chemoreceptor activity in cats. J Pharmacol Exp Ther 197:119-125, 1976

30. Perkin GD, AMINOFF MJ: A trial of brolitene in the treatment of spasticity. Br J Clin Pharmacol 3:879-882, 1976

31. AMINOFF MJ, Layzer RB, Satya-Murti S, Faden AI: Declining electrical response of muscle to repetitive nerve stimulation in myotonia. Neurology 27:812-816, 1977

32. Wilcox CS, AMINOFF MJ, Slater JDH: Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 53:321-328, 1977

33. AMINOFF MJ, Jaffe RA, Sampson SR, Vidruk EH: Effect of droperidol on activity of carotid body chemoreceptors in cats. Br J Pharmacol 63:245-250, 1978

34. AMINOFF MJ: Neurological disorders and pregnancy. Am J Obstet Gynecol 132:325-335, 1978 15

35. AMINOFF MJ, Dedo HH, Izdebski K: Clinical aspects of spasmodic dysphonia. J Neurol Neurosurg Psychiatry 41:361-365, 1978

36. AMINOFF MJ, Ehsanullah RSB, Turner P: Uptake of dopamine and 5-hydroxytryptamine by platelets of patients with Parkinsonism. J Neurol Neurosurg Psychiatry 41:589-592, 1978

37. AMINOFF MJ: Diagnosis and treatment of spinal arteriovenous malformations. Weekly Update: Neurology and Neurosurgery 2:14-18, 1979

38. AMINOFF MJ: Involvement of peripheral vasomotor fibres in patients with carpal tunnel syndrome. J Neurol Neurosurg Psychiatry 42:649-655, 1979

39. AMINOFF MJ: Peripheral sympathetic function in patients with a polyneuropathy. J Neurol Sci 44:213-219, 1980

40. Ochs AL, AMINOFF MJ: Effect of adaptation to the stimulating pattern on latency and waveform of visual evoked potentials. Electroencephalogr Clin Neurophysiol 48:502-508, 1980

41. Ochs AL, AMINOFF MJ: Visual evoked potentials elicited by circular grating. Arch Neurol 37:308-309, 1980

42. Arruga J, Feldon SE, Hoyt WF, AMINOFF MJ: Monocularly and binocularly evoked visual responses to patterned hemifield stimulation. J Neurol Sci 46:281-290, 1980

43. Stahl SM, Layzer RB, AMINOFF MJ, Townsend J, Feldon S: Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 30:1115-1118, 1980

44. AMINOFF MJ, Simon RP: Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 69:657-666, 1980

45. AMINOFF MJ: The drug treatment of epilepsy. Compr Ther 7:6-12, 1981

46. Asher SW, AMINOFF MJ: Tetrabenazine and movement disorders. Neurology 31:1051-1054, 1981

47. AMINOFF MJ, Ochs AL: Pattern-onset visual evoked potentials in suspected multiple sclerosis. J Neurol Neurosurg Psychiatry 44:608-614, 1981

48. Greenberg DA, Weinkle DJ, AMINOFF MJ: Periodic EEG complexes in infectious mononucleosis encephalitis. J Neurol Neurosurg Psychiatry 45:648-651, 1982

49. Mueller J, AMINOFF MJ: Tourette-like syndrome after long-term neuroleptic drug treatment. Br J Psychiatry 141:191-193, 1982.

50. Maitland CG, AMINOFF MJ, Kennard C, Hoyt WF: Evoked potentials in the evaluation of visual field defects due to chiasmal or retrochiasmal lesions. Neurology 32:986-991, 1982

51. Lotti M, Becker CE, AMINOFF MJ: Occupational peripheral neuropathies. Western J Med 137:493-498, 1982 16

52. Lotti M, Becker CE, AMINOFF MJ, Woodrow JE, Seiber JN, Talcott RE, Richardson RJ: Occupational exposure to the cotton defoliants DEF and merphos. A rational approach to monitoring organophosphorous-induced neurotoxicity. J Occup Med 25:517-522, 1983

53. Lukes SA, Crooks E, AMINOFF MJ, Kaufman L, Panitch HS, Mills C, Norman D: Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol 13:592-601, 1983

54. Lukes SA, AMINOFF MJ, Crooks L, Kaufman L, Mills C, Newton TH: Nuclear magnetic resonance imaging in movement disorders. Ann Neurol 13:690-691, 1983

55. Goodin DS, AMINOFF MJ: Relationship between the evoked potential and brain events in sensory discrimination and motor response. Brain 107:241-251, 1984

56. Lotti M, Becker CE, AMINOFF MJ: Organophosphate polyneuropathy: Pathogenesis and prevention. Neurology 34:658-662, 1984

57. AMINOFF MJ, Simon RP, Wiedemann E: Hormonal responses to generalized tonic-clonic seizures. Brain 107:569-578, 1984

58. Simon RP, AMINOFF RJ, Benowitz NL: Changes in plasma catecholamines after tonic-clonic seizures. Neurology 34:255-257, 1984

59. Goodin DS, AMINOFF MJ: Does the interictal EEG have a role in the diagnosis of epilepsy? Lancet 1:837-839, 1984

60. AMINOFF MJ: The clinical role of somatosensory evoked potential studies: A critical appraisal. (AAEE Minimonograph No. 22) Muscle & Nerve 7:345-354, 1984

61. Wilcox CS, Puritz R, Lightman SL, Bannister R, AMINOFF MJ: Plasma volume regulation in patients with progressive autonomic failure during changes in salt intake or posture. J Lab Clin Med 104:331-339, 1984

62. Feinberg I, March JD, Floyd TC, Fein G, AMINOFF MJ: Log amplitude is a linear function of log frequency in NREM sleep EEG of young and elderly normal subjects. Electroencephalogr Clin Neurophysiol 58:158-160, 1984

63. AMINOFF MJ, Davis SL, Panitch HS: Serial evoked potential studies in patients with definite multiple sclerosis: clinical relevance. Arch Neurol 41:1197-1202, 1984

64. Goodin DS, Waltz DA, AMINOFF MJ: Task dependent hemisphere asymmetries of the visual evoked potential. Neurology 35:378-384, 1985

65. Davis SL, AMINOFF MJ, Berg B: Brainstem auditory evoked potentials in children with brainstem or cerebellar dysfunction. Arch Neurol 42:156-160, 1985

66. Davis SL, AMINOFF MJ, Panitch HS: Clinical correlations of serial somatosensory evoked potentials in multiple sclerosis. Neurology 35:359-365, 1985 17

67. AMINOFF MJ: Electrophysiologic recognition of certain occupation-related neurotoxic disorders. Neurol Clin 3:687-697, 1985

68. AMINOFF MJ: Electrophysiologic evaluation of patients with multiple sclerosis. Neurol Clin 3:663-674, 1985

69. AMINOFF MJ, Goodin DS, Barbaro NM, Weinstein PR, Rosenblum ML: Dermatomal somatosensory evoked potentials in unilateral lumbosacral radiculopathy. Ann Neurol 17:171-176, 1985

70. AMINOFF MJ, Goodin DS, Parry GJ, Barbaro NM. Weinstein PR, Rosenblum ML: Electrophysiologic evaluation of lumbosacral radiculopathies: Electromyography, late responses and somatosensory evoked potentials. Neurology 35:1514-1518, 1985

71. AMINOFF MJ: Autonomic insufficiency and its evaluation. Medicine (North America) 34:4863-4871, 1986

72. AMINOFF MJ: Evoked potentials in clinical medicine. Q J Med 59:345-362, 1986

73. Goodin DS, AMINOFF MJ, Mantle MM: Subclasses of event-related potentials: response- locked and stimulus-locked components. Ann Neurol 20:603-609, 1986

74. AMINOFF MJ: Management of unruptured cerebral arteriovenous malformations. Clin Neurosurg 33:177-185, 1986

75. Simon RP, AMINOFF MJ: Electrographic status epilepticus in fatal anoxic coma. Ann Neurol 20:351-355, 1986

76. Guazelli M, Feinberg I, AMINOFF M, Fein G, Floyd TC, Maggini C: Sleep spindles in normal elderly: Comparison with young adult patterns and relation to nocturnal awakening, cognitive function and brain atrophy. Electroencephalogr Clin Neurophysiol 63:526-539, 1986

77. Cutler JR, AMINOFF MJ, Brant-Zawadski M: Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: A comparative study. Ann Neurol 20:645-648, 1986

78. AMINOFF MJ, Simon RP, Wiedemann E: Effect on plasma prolactin levels of interictal epileptiform EEG activity. J Neurol Neurosurg Psychiatry 49:702-705, 1986

79. Goodin DS, AMINOFF MJ: Electrophysiological differences between subtypes of dementia. Brain 109:1103-1113, 1986

80. AMINOFF MJ, Goodin DS, Habermann-Little B, Cutler JR: Treatment of Parkinson's disease with ciladopa. Ann Neurol 21:311, 1987

81. Goodin DS, AMINOFF MJ: Electrophysiological differences between demented and nondemented patients with Parkinson's disease. Ann Neurol 21:90-94, 1987

82. AMINOFF MJ: Treatment of unruptured cerebral arteriovenous malformations. Neurology 37:815-819, 1987

83. AMINOFF MJ: Use of somatosensory evoked potentials to evaluate the peripheral nervous system. J Clin Neurophysiol 4:135-144, 1987

84. AMINOFF MJ: Parkinson's disease in the elderly: current management strategies. Geriatrics 42:31-37, 1987

85. Parry GJ, AMINOFF MJ: Somatosensory evoked potentials in chronic acquired demyelinating peripheral neuropathy. Neurology 37:313-316, 1987

86. Shefrin SL, Goodin DS, AMINOFF MJ: Electrophysiological evidence of visual processing in a blind field. Electroencephalogr Clin Neurophysiol Supplement 40:752-755, 1987

87. Goodin DS, AMINOFF MJ: The distinction between different types of dementia using evoked potentials. Electroencephalogr Clin Neurophysiol Supplement 40:695-698, 1987

88. Goodin DS, AMINOFF MJ, Mantle MM: Sensory discrimination and its relationship to the cerebral processing of infrequent stimuli. Can J Neurol Sci 14:642-648, 1987

89. Lowenstein DH, AMINOFF MJ: Clinical course of spasmodic torticollis. Neurology 38:530-532, 1988

90. Lowenstein DH, AMINOFF MJ, Simon RP: Barbiturate anesthesia in the treatment of status epilepticus: Clinical experience in 14 patients. Neurology 38:395-400, 1988

91. AMINOFF MJ, Gutin PH, Norman D: Unusual type of spinal arteriovenous malformation. Neurosurgery 22:589-591, 1988

92. AMINOFF MJ, Olney RK, Parry GJ, Raskin NH: Relative utility of different electrophysiologic techniques in the evaluation of brachial plexopathies. Neurology 38:546-550, 1988

93. Wilbourn AJ, AMINOFF MJ: Electrophysiologic examination in patients with compressive radiculopathies. An AAEE Minimonograph. Muscle Nerve 11:1099-1114, 1988

94. AMINOFF MJ, Goodin DS, Berg BO, Compton MN: Ambulatory EEG recordings in epileptic and nonepileptic children. Neurology 38:558-562, 1988

95. Shefrin SL, Goodin DS, AMINOFF MJ: Visual evoked potentials in the investigation of “blindsight.” Neurology 38:104-109, 1988

96. AMINOFF MJ, Scheinman MM, Griffin JC, Herre JM: Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias. Ann Intern Med 108:791-796, 1988

97. Reisin RC, Goodin DS, AMINOFF MJ, Mantle MM: Recovery of peripheral and central responses to median nerve stimulation. Electroencephalogr Clin Neurophysiol 69:585-588, 1988

98. AMINOFF MJ: Use of somatosensory evoked potentials in the evaluation of the central nervous system. Neurol Clin 6:809-823, 1988 19

99. Shih P-Y, AMINOFF MJ, Goodin DS, Mantle MM: Effect of reference point on visual evoked potentials: clinical relevance. Electroencephalogr Clin Neurophysiol 71:319-322, 1988

100. Olney RK, AMINOFF MJ, Gelb DJ, Lowenstein DH: Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology 38:1780-1783, 1988

101. Reisin RC, Goodin DS, AMINOFF MJ, Mantle MM: Effects of different sensory inputs on the median-derived somatosensory evoked potential. Muscle Nerve 12:598-603, 1989

102. Gelb DJ, Lowenstein DH, AMINOFF MJ: Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 39:80-84, 1989

103. So YT, Olney RK, AMINOFF MJ: Evaluation of thermography in the diagnosis of selected entrapment neuropathies. Neurology 39:1-5, 1989

104. AMINOFF MJ: Management strategies for patients with Parkinson's disease. New Devel in Med 4:31-39, 1989

105. Clark MR, AMINOFF MJ, Chiu DT-Y, Kuypers FA, Friend DS: Red cell deformability and lipid composition in two forms of acanthocytosis: enrichment of acanthocytic populations by density gradient centrifugation. J Lab Clin Med 113:469-481, 1989

106. AMINOFF MJ: Intraoperative monitoring by evoked potentials for spinal cord surgery: the cons. Electroencephalogr Clin Neurophysiol 73:378-380, 1989

107. So YT, AMINOFF MJ, Olney RK: The role of thermography in the evaluation of lumbo-sacral radiculopathy. Neurology 39: 1154-1158, 1989

108. Olney RK, AMINOFF MJ: Electrodiagnostic features of the Guillain-Barre syndrome: the relative sensitivity of different techniques. Neurology 40:471-475, 1990

109. Goodin DS, AMINOFF MJ, Shefrin SL: The organization of sensory discrimination and response selection in choice and nonchoice conditions: a study using cerebral evoked potentials in normal humans. J Neurophysiol 64:1270-1281, 1990

110. Goodin DS, AMINOFF MJ, Shih PY: Evidence that the long-latency stretch responses of the human wrist extensor muscle involve a transcerebral pathway. Brain 113:1075-1091, 1990

111. Goodin DS, AMINOFF MJ, Laxer KD: Detection of epileptiform activity by different noninvasive EEG methods in complex partial epilepsy. Ann Neurol 27:330-334, 1990

112. Olney RK, So YT, Goodin DS, AMINOFF MJ: A comparison of magnetic and electrical stimulation of peripheral nerves. Muscle Nerve 13:957-963, 1990

113. Goodin DS, AMINOFF MJ, Chernoff DN, Hollander H: Long latency event-related potentials in patients infected with human immunodeficiency virus. Ann Neurol 27:414-419, 1990 20

114. AMINOFF MJ: Evoked potential studies in neurological diagnosis and management. (Invited peer-reviewed review) Ann Neurol 28:706-710, 1990

115. AMINOFF MJ: Segmentally specific somatosensory evoked potentials. Neurol Clin 9:663-669, 1991

116. AMINOFF MJ, Olney RK, So YT: Thermography and the evaluation of neuromuscular disorders. Semin Neurol 10:150-155, 1990

117. So YT, Olney RK, AMINOFF MJ: A comparison of thermography and electromyography in the diagnosis of cervical radiculopathy. Muscle Nerve 13:1032-1036, 1990

118. AMINOFF MJ, Goodin DS, Olney RK, So YT: Clinical neurophysiology of HIV infection. Riv Neurobiol 37:7-13, 1991

119. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, AMINOFF MJ: Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 29:370-376, 1991

120. Olney RK, AMINOFF MJ, So YT: Clinical and electrodiagnostic features of x-linked recessive bulbospinal neuronopathy. Neurology 41:823-828, 1991

121. Chequer RS, Goodin DS, AMINOFF MJ: The nature of the suprasegmental influences on the late EMG responses in human forearm muscles. Brain Res 566:284-289, 1991

122. Goodin DS, AMINOFF MJ, Chequer R: The effect of different high-pass filters on the long latency event-related auditory evoked potentials in normal human subjects and individuals infected with human immunodeficiency virus. J Clin Neurophysiol 9:97-104, 1992

123. Lowenstein DH, AMINOFF MJ: Clinical and EEG features of status epilepticus in comatose patients. Neurology 42:100-104, 1992

124. Yoshimura DM, AMINOFF MJ, Olney RK: Botulinum toxin therapy for limb dystonias. Neurology 42:627-630, 1992

125. Goodin DS, AMINOFF MJ: The basis and functional role of the late EMG activity in human forearm muscles following wrist displacement. Brain Res 589:39-47, 1992

126. AMINOFF MJ: Neurological problems during pregnancy. Int Rev Anesthesiol 1:311-313,1992

127. Yoshimura DM, AMINOFF MJ, Tami TA, Scott AB: Treatment of hemifacial spasm with botulinum toxin Muscle Nerve 15:1045-1049, 1992

128. AMINOFF MJ: Autonomic dysfunction in central nervous system disorders. Curr Opin Neurol Neurosurg 5:482-486, 1992

129. Goodin DS, AMINOFF MJ: Evaluation of dementia by event-related potentials. J Clin Neurophysiol 9:521-525, 1993

130. Ortiz TA, Goodin DS, AMINOFF MJ: Neural processing in a three-choice reation-time task: a study using cerebral-evoked potentials and simple-trial analysis in normal humans. J Neurophysiol 69:1499-1512, 1993

131. Goodin DS, AMINOFF MJ, Ortiz TA: Expectancy and response strategy to sensory stimuli. Neurology 43:2139-2142, 1993

132. Chequer R, Goodin DS, AMINOFF MJ, Maeztu C: Late electromyographic activity following stretch in human forearm muscles: physiological role Brain Res 641: 273-278, 1994

133. AMINOFF MJ: Treatment of Parkinsons' disease. (Invited review) West J Med 161:303-308, 1994

134. AMINOFF MJ. Goodin DS: Visual evoked potentials. J Clin Neurophysiol 11:493-499, 1994

135. Garcia PA, AMINOFF MJ, Goodin DS: Frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. Neurology 45:989-992, 1995

136. Nakajima M, Eisen A, McCarthy R, Olney RK, AMINOFF MJ: Reduced corticomotoneuronal excitatory postsynaptic potentials (EPSPs) with normal Ia afferent EPSPs in amyotrophic lateral sclerosis. Neurology 47:1555-1561, 1996

137. Goodin DS, AMINOFF MJ: Nonrandom behavior in a reaction-time time-series. Muscle Nerve 19:1183-1185, 1996

138. Goodin DS, AMINOFF MJ, Ortiz TA, Chequer RS: Response times and handedness in simple reaction-time tasks. Exp Brain Res 109:117-126, 1996

139. AMINOFF MJ: Brown-Séquard and his syndrome. J Hist Neurosci 5:14-20, 1996

140. AMINOFF MJ: The clinical neurophysiology of cortical sensorimotor function. J Clin Neurophysiol 13:219-226, 1996

141. AMINOFF MJ: Brown-Séquard and his work on the spinal cord. Spine 21:133-140, 1996

142. Goodin DS, AMINOFF MJ, Chequer RS, Ortiz TA: Response compatibility and the relationship between event-related potentials and the timing of a motor response. J Neurophysiol 76:3705-3713, 1996

143. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Roberts TPL: Comparison of late components in simultaneously recorded event-related electrical potentials and event-related magnetic fields. Electroencephalogr Clin Neurophysiol 99:191-197, 1996

144. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Roberts TPL: The correlation coefficient and the goodness of fit in source localization of noise recorded by magnetoencephalography. Brain Topogr 9:95-100, 1996

145. AMINOFF MJ, Goodin DS: The decision to make a movement: neurophysiological insights. Can J Neurol Sci 24:181-190, 1997

146. Engstrom JW, AMINOFF MJ: Evaluation and treatment of orthostatic hypotension (Invited review). Am Fam Phys 56:1378-1384, 1997 22

147. Low PA, Gilden JL, Freeman RL, Sheng KN, McElligott MA, for the Midodrine Study Group (AMINOFF MJ, et al): Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA 277:1046-1051, 1997

148. Jobst EE, Melnick ME, Byl NN, Dowling GA, AMINOFF MJ: Sensory perception in Parkinson’s disease. Arch Neurol 54:450-454, 1997

149. Knowlton RC, Laxer KD, AMINOFF MJ, Roberts TPL, Wong STC, Rowley HA: Magnetoencephalography in partial epilepsy: clinical yield and localization accuracy. Ann Neurol 42:622-631, 1997

150. Shannon KM, Bennett JP, Friedman JH, for the Pramipexole Study Group (AMINOFF MJ, et al): Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson’s disease Neurology 49:724-728, 1997

151. Gottwald MD, Bainbridge JL, Dowling GA, AMINOFF MJ, Alldredge BK: New pharmacotherapy for Parkinson’s disease. Ann Pharmacother 31:1205-1217, 1997

152. AMINOFF MJ, Siedenberg R, Goodin DS: Changes of forearm EMG and cerebral evoked potentials following sudden muscle stretch during isometric contractions in patients with Parkinson’s disease. Brain Res 757:254-259, 1997

153. Cruz CJ, AMINOFF MJ, Meyerhoff DJ, Graham SH, Weiner MW: Proton MR spectroscopic imaging of the striatum in Parkinson’s disease Magn Reson Imaging 15:619-624, 1997

154. AMINOFF MJ, Eisen A: Somatosensory evoked potentials. Muscle Nerve 21:277-290, 1998

155. Wilbourn AJ, AMINOFF MJ: The electrodiagnostic examination in patients with radiculopathies. Muscle Nerve 21:1612-1631, 1998

156. AMINOFF MJ: Do nonconvulsive seizures damage the brain? No. Arch Neurol 55:119-120, 1998

157. AMINOFF MJ: Management of status epilepticus Can J Neurol Sci 25:S4-S6, 1998

158. Goodin DS, AMINOFF MJ: Event-related potentials in the study of sensory discrimination and motor response in simple and choice reaction tasks. J Clin Neurophysiol 15:34-43, 1998

159. Janavs JL, AMINOFF MJ: Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 65:436-445, 1998

160. Kutukcu Y, Marks WJ Jr, Goodin DS, AMINOFF MJ: Cerebral accompaniments to simple and choice reaction tasks in Parkinson’s disease Brain Res 799:1-5, 1998

161. Goodin DS, AMINOFF MJ, Kutukcu Y, Marks WJ Jr: Order effects in response times of parkinsonian patients and normal controls. Muscle Nerve 22:567-572, 1999

162. Lomen-Hoerth C, AMINOFF MJ: Clinical neurophysiologic studies: which test is useful and when? 23

Neurol Clin 17:65-74, 1999

163. Kutucka Y, Marks WJ Jr, Goodin DS, Aminoff MJ: Simple and choice reaction time in Parkinson's disease. Brain Res 815:367-372, 1999

164. Melnick ME, Dowling GA, AMINOFF MJ, Barbaro NM: Effects of pallidotomy on postural control and motor function in Parkinson disease. Arch Neurol 56:1361-1365, 1999

165. Siedenberg R. Goodin DS, AMINOFF MJ: Changes of forearm EMG and cerebral evoked potentials following sudden muscle stretch in patients with Huntington's disease. Muscle Nerve. 22:1557-1563, 1999

166. AMINOFF MJ, Goodin DS: Studies of the human stretch reflex. Muscle Nerve Suppl 9:S3-S6, 2000

167. Smith WS, AMINOFF MJ: Introduction to monitoring in the neurological intensive care unit and its future impact. Neurologist 6:83-97, 2000

168. AMINOFF MJ: Parkinson's disease Neurol Clin 19: 119-128, 2001

169. Goetz CG, AMINOFF MJ: The Brown-Sequard and S. Weir Mitchell letters. Neurology 57:2100-2104, 2001

170. O'Neill JO, Schuff N, Marks WJ, Feiwell R, AMINOFF MJ, Weiner MW: Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 17:917-927, 2002

171. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally M, Foroud T, and the Parkinson Study Group (AMINOFF MJ et al): Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet 71:124-135, 2002

172. AMINOFF MJ: Electrophysiological evaluation of root and spinal cord disease. Semin Neurol 22: 197-204, 2002

173. Parkinson Study Group (AMINOFF MJ, participating investigator and author): A controlled trial of rasagiline in early Parkinson disease. The TEMPO study. Arch Neurol 59: 1937-1943, 2002

174. Reider CR and the Parkinson Study Group (AMINOFF MJ, participating investigator and author): Reliability of reported age at onset for Parkinson’s disease. Mov Disord 18:275-279, 2003

175. Foroud T and the Parkinson Study Group (AMINOFF MJ, participating investigator and author): Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 60:796-801, 2003

176. Pankratz N and the Parkinson Study Group (AMINOFF MJ, participating investigator and author): Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 72:1053-1057, 2003

177. Weiskopf RB, AMINOFF MJ, Hopf HW, Feiner J, Viele MK, Watson JJ, Ho R, Songster C, Toy P: Acute isovolemic anemia does not impair peripheral or central nerve conduction. Anesthesiology 99:546-551, 2003

178. Assaf BA, Karkar KM, Laxer KD, Garcia PA, Austin EJ, Barbaro NM, AMINOFF MJ: Ictal Magnetoencephalography in temporal and extratemporal lobe epilepsy. Epilepsia 44: 1320-1327, 2003

179. Leppert D, Goodin DS, AMINOFF MF: Stimulus recognition and its relationship to the cerebral event-related potential. Neurology 61:1533-1537, 2003

180. AMINOFF MJ: Neuroprotective treatment for Parkinson’s disease. Expert Rev Neurotherapeutics 3: 797-804, 2003

181. Dowling GA, Mastick J, AMINOFF MJ: Melatonin for sleep disturbances in Parkinson’s disease: a pilot study. Sleep Res Online 5:99-103, 2003 http://www.sro.org/2003/Dowling/99/

182. Pankratz N and the Parkinson Study Group (AMINOFF MJ, participating investigator): Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet 12: 2599-2608, 2003

183. Parkinson Study Group (AMINOFF MJ, co-author and participating investigator): A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol 61: 561-566, 2004

184. AMINOFF MJ: Electrophysiologic testing for the diagnosis of peripheral nerve injuries. Anesthesiology 100:1298-303, 2004

185. Christine CW, AMINOFF MJ: Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. Am J Med 117: 412-419, 2004

186. Assaf BA, Karkar KM, Laxer KD, Garcia PA, Austin EJ, Barbaro NM, AMINOFF MJ: Magnetoencephalography source localization and surgical outcome in temporal lobe epilepsy. Clin Neurophysiol 115:2066-2076, 2004

187. Nichols WC and the Parkinson Study Group (AMINOFF MJ, participating investigator and co- author): Evaluation of the role of Nurr1 in a large sample of familial Parkinson’s disease. Mov Disord 19: 649-655, 2004

188. Pankratz N and the Parkinson Study Group (AMINOFF MJ, participating investigator and co- author): Genes influencing Parkinson disease onset: replication of Park3 and identification of novel loci. Neurology 62: 1616-1618, 2004

189. AMINOFF MJ: EEG monitoring of comatose patients in the intensive care unit. Suppl Clin Neurophysiol 57:662-666, 2004

190. Parkinson Study Group (AMINOFF MJ, co-author and participating investigator): A randomized, placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations. The PRESTO study. Arch Neurol 62: 241-248, 2005

191. Lieberman MA, Winzelberg A, Golant M, Wakahira M, DiMinno M, AMINOFF M, Christine C: Online support groups for Parkinson’s patients: a pilot study of effectiveness. Soc Work Health Care 42: 23-38, 2005

192. Weiskopf RB, Toy P, Hopf HW, Feiner J, Finlay HE, Takahashi M, Mostrom A, Songster C, AMINOFF M: Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 116:1028-1032, 2005

193. Nichols WC et al for the Parkinson Study Group—PROGENI investigators (AMINOFF MJ, participating investigator): genetic screening for a single common LRRK2 mutation in familial Parkinson’s disease. (Research letter) Lancet 365:410-412, 2005

194. Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, AMINOFF MJ: Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 6: 459-466, 2005

195. AMINOFF MJ: Treatment should not be initiated too soon in Parkinson's disease. Ann Neurol 59:562-564, 2006

196. Parkinson Study Group (AMINOFF MJ, participating investigator and author): A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Arch Neurol 63: 210-216,2006

197. The NINDS NET-PD Investigators (AMINOFF MJ, participating investigator and author): A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson’s disease. Neurology 66: 664-671, 2006

198. Tilley BC et al on behalf of The NINDS NET-PD Investigators (AMINOFF MJ, participating investigator and author): Optimizing the ongoing search for new treatments for Parkinson’s disease: using futility designs. Neurology 66: 628-633, 2006

199. Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I, and the Parkinson Study Group TEMPO and PRESTO Investigators (AMINOFF MJ, participating investigator in TEMPO and PRESTO studies and co-author of report): Safety of rasagiline in elderly patients with Parkinson disease. Neurology 66: 1427-1429, 2006

200. Nakamura K, AMINOFF MJ: Huntington's disease: clinical characteristics, pathogenesis and therapies Drugs Today (Barc) 43:97-116, 2007

201. The NINDS NET-PD Investigators (AMINOFF MJ, participating investigator and author): A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson’s disease. Neurology 68: 20-28, 2007

202. Simon DK, Swearingen CJ, Hauser RA, Trugman JM, AMINOFF MJ et al: Caffeine and the progression of Parkinson’s disease. Clin Neuropharmacol 31:189-196, 2008

203. AMINOFF MJ: The training of neurologists. Neurology 70:1912-1915, 2008

204. Gottwald MD, AMINOFF MJ: New frontiers in the pharmacologic management of Parkinson’s disease. Drugs Today (Barc) 44:531-545, 2008

205. Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, AMINOFF MJ: Results from a phase I safety trial of hAADC gene therapy for Parkinson’s disease. Neurology 70:1980-1983, 2008 26

206. NINDS NET-PD Investigators (AMINOFF MJ, participating investigator and author): A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol 31:141-150, 2008

207. Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators (AMINOFF MJ, participating investigator and author): Clinical correlates of depressive symptoms in familial Parkinson's disease. Mov Disord 23:2216-2223, 2008

208. Ralph JW, Goodin DS, Long JM, AMINOFF MJ: Electrical brain events associated with awareness of errors. Brain Res 1251:213-222, 2009

209. Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators (AMINOFF MJ, participating investigator and author): Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 72:310-316, 2009

210. Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, AMINOFF MJ: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73: 1662-1669, 2009

211. Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group. (AMINOFF MJ, participating investigator and author): Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Mov Disord 15:564-573, 2009

212. Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators. (AMINOFF MJ, participating investigator and author): Variation in GIGYF2 is not associated with Parkinson disease. Neurology 72:1886-1892, 2009

213. Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators. (AMINOFF MJ, participating investigator and author): Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology 73:279-286, 2009

213. Douglas VC, DeArmond SJ, AMINOFF MJ, Miller BL, Rabinovici GD: Seizures in corticobasal degeneration: A case report. Neurocase 15: 352-356, 2009

214. Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T; PROGENI Investigators, Coordinators and Molecular Genetic Laboratories; GenePD Investigators,

Coordinators and Molecular Genetic Laboratories [AMINOFF MJ, participating investigator and author): Genomewide association study for onset age in Parkinson disease. BMC Med Genet. 10:98, September 22, 2009

214. Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators [AMINOFF MJ, participating investigator and author): Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease. BMC Med Genet 11:53, April 1, 2010

215. Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators [AMINOFF MJ, participating investigator and author): Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Mov Disord 25:1082-1086, 2010

216. Tien I, Glaser SD, Bajcsy R, Goodin DS, Aminoff MJ: Results of using a wireless inertial measuring system to quantify gait motions in control subjects. IEEE Trans Inf Technol Biomed 14:904-915, 2010

217. Tien I, Glaser SD, AMINOFF MJ: Characterization of gait abnormalities in Parkinson's disease using a wireless inertial sensor system. Conf Proc IEEE Eng Med Biol Soc 1:3353-3356,2010

218. Forsayeth J, Bankiewicz KS, AMINOFF MJ: Gene therapy for Parkinson's disease: where are we now and where are we going? Expert Rev Neurother 10:1839-1845, 2010

219. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, AMINOFF MJ, Bankiewicz KS: Qualitative imaging of adeno- associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery 75:1377-1385. 2010

220. AMINOFF MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, Oberdorf J, Schmidt P, Okun MS; for the National Parkinson Foundation Working Group on Hospitalization in Parkinson’s Disease: Management of the hospitalized patient with Parkinson's disease: Current state of the field and need for guidelines. Parkinsonism Relat Disord 17:139-145, 2011

221. Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine CW, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, AMINOFF MJ, Malaty IA, Friedman JH, Okun MS: Hospitalization in Parkinson disease: A survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord;17:440-445, 2011

222. Gottwald MD, Aminoff MJ: Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Ann Neurol 69:919-927, 2011

223. Voss TS, Elm JJ, Wielinski CL, AMINOFF MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC. Fall frequency and risk assessment in early Parkinson's disease. Parkinsonism Relat Disord 18:837-841, 2012

224. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine CW, AMINOFF MJ, Hellerstein MK: Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest 122:3159-169, 2012 225. Elm JJ; NINDS NET-PD Investigators (AMINOFF MJ, participating investigator and author): Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord 27:1513-1521, 2012

EDITORIALS & COMMENTARIES

1. AMINOFF MJ: The use of animals in science. Neurology 43:1875-1877, 1993

2. AMINOFF MJ: Sensory modulation and the spinal cord. Ann Neurol 34:511-512, 1993

3. AMINOFF MJ: Criticism in neurology and medicine. Neurology 44:1781-1783, 1994

4. Landau WM, Daube JR, AMINOFF MJ, Brey RL, Brooks BR, et al. The genuine threat to neurologic research from the animal radical right. Neurology 45:609-610, 1995 J Child Neurology 10:343-345, 1995 5. AMINOFF MJ: Brown-Séquard J Hist Neurosci 5:5-6, 1996

6. AMINOFF MJ: Parkinson’s disease: a progress report. West J Med 165:248-250, 1996

7. McCarthy RJ, AMINOFF MJ: Electrophysiological tests of autonomic function in patients with idiopathic autonomic failure syndromes. Neurol Network Comm 1:1-4, 1997

8. Goodin DS, AMINOFF MJ: Dermatomal/segmental somatosensory evoked potential evaluation of L5/S1 unilateral/unilevel radiculopathies. Neurol Network Comm 1:151-153, 1997

9. AMINOFF MJ: Message from the editor. Muscle Nerve 21:2, 1998

10. AMINOFF MJ: Message from the editor Muscle Nerve 22:1, 1999

11. AMINOFF MJ: Message from the editor Muscle Nerve 23:1, 2000 29

12. AMINOFF MJ: Message from the editor Muscle Nerve 24:1, 2001

13. Rosenberg RN, AMINOFF MJ, Boller F, Soerenson PS, et al: Reporting clinical trials: full access to all the data. Arch Neurol 59:27-28, 2002 Mov Disord 17:3-4, 2002 Muscle Nerve 25:133-134, 2002 Brain 125:l-2, 2002 Eur J Neurol 9:123-124, 2002 J Neurol 249:638-639, 2002 J Neurol Neurosurg Psychiatry 72:143, 2002

14. AMINOFF MJ: Electronic processing of manuscripts. Muscle Nerve 33:301, 2006

15. AMINOFF MJ, Massey JM, Scheiber SC, Juul D: Certification in neuromuscular medicine: a new neurologic subspecialty. Neurology 68:1153-1154, 2007 Muscle Nerve 35:409-410, 2007

16. Faulkner LR, Tivnan PW, Johnston MV, AMINOFF MJ, Coyle PK, Crumrine PK, DeKosky ST, Jozefowicz R, Massey JM, Pascuzzi RM: The ABPN maintenance of certification program for neurologists: past, present, and future. Neurology 71:599-604, 2008

17. Faulkner LR, Juul D, Pascuzzi RM, Aminoff MJ, Crumrine PK, Dekosky ST, Jozefowicz RF, Massey JM, Pirzada N, Tilton A: Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology 75:1110-1107, 2010

BOOKS (new editions are listed under the original title and not listed or numbered separately; the total is 29, excluding the series of books of which I am series editor)

1. AMINOFF MJ: Spinal Angiomas. Blackwell: Oxford, 1976.

2. AMINOFF MJ: Electromyography in Clinical Practice. 1st Edition. Addison Wesley: Reading, Mass., 1978.

3. AMINOFF MJ (Ed): Electrodiagnosis in Clinical Neurology. Churchill Livingstone: New York. a. First Edition, 1980. b. Second Edition, 1986. c. Third Edition, 1992. d. Fourth Edition, 1999. e. Fifth Edition, 2005, f. Sixth Edition, 2012

4. Consultant in neurology and neurophysiology and Asst. Editor for the Encyclopedia and Dictionary of Laboratory Medicine and Technology, Bennington JL (Ed), Saunders: Philadelphia, 1984.

5. AMINOFF MJ (Ed):Electrodiagnosis issue, Neurologic Clinics. Saunders: Philadelphia, 1985 Portuguese (Brazilian) translation published as a separate book, 1987.

6. AMINOFF MJ: Electromyography in Clinical Practice. Electrodiagnostic Aspects of Neuromuscular Disease. a. 2nd Edition (expanded). Churchill Livingstone: New York, 1987. b. 3rd Edition, Churchill Livingstone: New York, 1998 30

7. a. Simon RP, AMINOFF MJ, Greenberg DA: Clinical Neurology. Appleton & Lange: Norwalk, 1989. Portuguese translation, 1991. Spanish (South American) translation, 1992. b. Greenberg DA, AMINOFF MJ , Simon RP: Clinical Neurology, 2nd Edition. Appleton & Lange, Norwalk, 1993. with Farsi, Spanish, and Portugese translations c. AMINOFF MJ, Greenberg DA, Simon RP: Clinical Neurology, 3rd Edition. Appleton & Lange, Norwalk, 1996. Spanish (South American) translation, 1998. d. Simon RP, AMINOFF MJ, Greenberg DA: Clinical Neurology, 4th Edition. Appleton & Lange, Norwalk, 1999. e Greenberg DA, Aminoff MJ, Simon RP: Clinical Neurology, 5th Edition McGraw-Hill, New York, 2002 Chinese translation, 2003 Spanish translation, 2003 Italian translation, 2004 Russian translation, 2004 Portuguese translation, 2005 f AMINOFF, MJ, Greenberg DA, Simon RP: Clinical Neurology, 6th Edition. McGraw-Hill, New York, 2005 Greek translation, 2007 g. Simon RP, AMINOFF MJ, Greenberg DA: Clinical Neurology, 7th Edition. McGraw-Hill, New York, 2009 Turkish translation, 2012 h. Greenberg DA, AMINOFF MJ, Simon RP: Clinical Neurology, 8th Edition. McGraw-Hill, New York, 2012

8. AMINOFF MJ (Ed): Neurology and General Medicine. Churchill Livingstone: New York. a. First Edition, 1989. b. Second Edition, 1995 c. Third Edition, 2001 Italian edition, 2004 (Delfino: Rome) d. Fourth edition, 2008

9. AMINOFF MJ: Brown-Sequard: A Visionary of Science. Raven Press, New York, 1993.

10. Goetz CG, Tanner CM, AMINOFF MJ (Eds): Handbook of Clinical Neurology, Volume 63: Systemic Disease, Part 1. Elsevier, Amsterdam, 1993.

11. Tollerud D, AMINOFF M, et al: Veterans and Agent Orange, a. Update 1996. National Academy Press, Washington, 1996. b Update 1998. National Academy Press, Washington, 1998. c. Herbicide/Dioxin exposure and type 2 diabetes. National Academy Press, Washington, 2000.

12. Goetz CG, AMINOFF MJ (Eds): Handbook of Clinical Neurology, Volume 70: Systemic Diseases, Part II, Elsevier, Amsterdam, 1998

13. AMINOFF MJ, Goetz CG (Eds): Handbook of Clinical Neurology, Volume 71: Systemic Diseases, Part III, Elsevier, Amsterdam, 1998

14. Brown WF, Bolton CF, AMINOFF MJ (Eds): Neuromuscular Function and Disease: Basic, Clinical and Electrodiagnostic Aspects. 2 Volumes. Saunders, Philadelphia, 2002

15. AMINOFF MJ, Daroff RB (Eds): Encyclopedia of the Neurological Sciences. 4 Volumes. Academic Press, San Diego, 2003

16. AMINOFF MJ: Brown-Sequard: An Improbable Genius Who Transformed Medicine. Oxford University press, New York, 2011

17. AMINOFF MJ, Faulkner L: The American Board of Psychiatry and Neurology: Looking Back and Moving Ahead. American Psychiatric Publishing, Washington, DC, 2012

Series Editor

Handbook of Clinical Neurology, 3rd series, edited by AMINOFF MJ, Boller F, Swaab D, Elsevier, Amsterdam. Vol 79: The Hypothalamus: Part 1, 2003 Vol 80: The Hypothalamus: Part 2, 2003 Vol 81: Pain, 2006 Vol 82: Motor Neuron Disorders and Related Diseases, 2007 Vol 83: Parkinson’s Disease and Related Disorders, Part 1, 2007 Vol 84: Parkinson’s Disease and Related Disorders, Part 2, 2007 Vol 85: HIV/AIDS and the Nervous System, 2007 Vol 86: Myopathies, 2007 Vol 87: Malformations of the Nervous System, 2007 Vol 88: Neuropsychology and Behavioral Neurology, 2008 Vol 89: Dementias, 2008 Vol 90: Disorders of Consciousness, 2008 Vol 91: Neuromuscular Junction Disorders, 2008 Vol 92: Stroke, Part I: Basic and Epidemiological Aspects, 2009 Vol 93: Stroke, Part II: Clinical Manifestations and Pathogenesis, 2009 Vol 94: Stroke, Part III: Investigation and Management, 2009 Vol 95: History of Neurology, 2010 Vol 96: Bacterial Infections of the Central Nervous System, 2010 Vol 97: Headache, 2011 Vol 98: Sleep Disorders, Part I, 2011 Vol 99: Sleep Disorders, Part II, 2011 Vol 100: Hyperkinetic Movement Disorders, 2011 Vol 101: Muscular Dystrophies, 2011 Vol 102: Neuro-Ophthalmology, 2011 Vol 103: Ataxic Disorders, 2012 Vol 104: Neuro-Oncology Part I, 2012 Vol 105: Neuro-Oncology Part II, 2012

As series editor, I have been responsible for selecting topics and volume editors for the series; reviewing the proposed table of content and authorship of each volume and amending as appropriate; reviewing each and every chapter with regard to content, scope, depth, and extent of coverage; and liaising with the production staff of the publisher.

BOOK CHAPTERS (Updates and new editions are listed under the original title and not numbered separately)

1. AMINOFF MJ: Electroencephalography. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York First edition, 1980, pp. 23-66. Second edition, 1986, pp. 21-75. Third edition. 1992, pp. 41-91. Fourth edition, 1999, pp. 37-80. Fifth edition, 2005, pp. 37-84. Sixth edition, 2012, pp. 37-84.

2. AMINOFF MJ: Electromyography. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York. First edition, 1980, pp. 197-228. Second edition, 1986, pp. 231-263. Third edition. 1992, pp. 249-281. Fourth edition, 1999, pp. 223-252. Fifth edition, 2005, pp. 233-260. Sixth edition, 2012, pp. 233-260.

3. AMINOFF MJ: Clinical Electrophysiology.In:Practice of Surgery, Volume on Neurosurgery, Hoff JT (Ed), Harper and Row: Hagerstown, Maryland, 1980. pp. 1-41.

4. AMINOFF MJ, Simon RP: Etiological, Clinical and Laboratory Features of Status Epilepticus. A Study of 98 Patients Seen in a Municipal General Hospital. In: Advances in Epileptology. The 12th Epilepsy International Symposium, Raven Press: New York, 1981. pp. 493-497.

5. AMINOFF MJ: Angiomas and Fistulae Involving the Nervous System. In: Vascular Disease of the Central Nervous System, Ross Russell RW (Ed), 2nd edition, Churchill Livingstone: Edinburgh, 1983. pp. 296-323.

6. AMINOFF MJ: Maternal neurologic disorders affecting pregnancy or fetal development. In: Maternal and Fetal Medicine : Principles and Practice, Creasy RK, Resnik R (Eds). Saunders: Philadelphia. First Edition, 1983. pp. 1005-1045. Second Edition, 1989, pp. 1073-1109. Third Edition, 1994, pp. 1071-1100. Fourth Edition, 1999, pp. 1091-1119 Fifth Edition, 2004, pp. 1165-1191 Sixth Edition, 2009, pp. 1089-1112

7. AMINOFF MJ: Neurologic disorders. In: Handbook of Medical Treatment, Watts DH (ed), 17th edition, Jones Medical: California, 1983. pp. 380-407.

8. AMINOFF MJ: Pharmacologic management of parkinsonism and other movement disorders. In: Basic and Clinical Pharmacology, Katzung B (Ed), Lange, Los Altos/ McGraw-Hill, New York First Edition, 1982, pp. 280-288. Second Edition, 1984, pp. 309-317. Third Edition, 1987, pp. 306-314. Fourth Edition, 1989, pp. 334-344. Fifth Edition, 1992, pp. 383-394. Sixth Edition, 1995, pp. 419-431. Seventh Edition, 1998, pp. 450-463. Eighth Edition, 2001, pp. 463-477. Ninth Edition, 2004, pp. 447-461. Tenth Edition, 2007, pp. 442-456. Eleventh Edition, 2009, pp. 469-485. Twelfth Edition, 2012, pp. 483-500.

9. Feinberg I, Fein G, Floyd TC, AMINOFF MJ: Delta (0.5-3Hz) EEG waveforms during sleep in young and elderly normal subjects. In: Sleep Disorders: Basic and Clinical Research, Chase MM (Ed), Spectrum Publications: New York, 1983, pp. 449-462.

10. AMINOFF MJ, Maitland CG, Kennard C, Hoyt WF: Visual evoked potentials and field defects. In: Evoked Potentials II: Proceedings of the 2nd International Evoked Potentials Symposium, Nodar R, Barber C (Eds), Butterworths: London. 1984. pp. 329-334.

11. AMINOFF MJ: Electromyography and nerve conduction studies. In Neurosurgery: The Scientific Basis of Clinical Practice, Crockard A, Hayward R, Hoff JT (Eds), Blackwell: Oxford, 1985. pp. 515-535.

12. AMINOFF MJ: Nervous system. In: Current Medical Diagnosis and Treatment, Lange: Los Altos/ McGraw-Hill, New York 1985 edition: pp. 581-630. 1986 edition: pp. 586-638. 1987 edition: pp. 571-622. 1988 edition: pp. 571-620. 1989 edition: pp. 607-658. 1990 edition: pp. 639-691. 1991 edition: pp. 677-730. 1992 edition: pp. 718-775. 1993 edition: pp. 729-785. 1994 edition: pp. 798-854. 1995 edition: pp. 827-883. 1996 edition: pp. 858-914. 1997 edition: pp. 892-948. 1998 edition: pp. 916-972. 1999 edition: pp. 932-989. 2000 edition: pp. 959-1018. 2001 edition: pp. 969-1027. 2002 edition: pp. 999-1057. 2003 edition: pp. 946-1005. 2004 edition: pp. 941-1000. 2005 edition: pp. 944-1006. 2006 edition: pp. 974-1037. 2007 edition: pp. 998-1062. 2008 edition: pp. 837-896. 2009 edition: pp. 848-911. 2010 edition: pp. 872-936. 2011 edition [with Geoffrey Kerschner]: pp. 927-994 2012 edition [with Geoffrey Kerschner]: pp. 936-1009.

13. Eisen A, AMINOFF MJ: Somatosensory evoked potentials. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York, Second edition, 1986, pp. 535-573. Third edition, 1992, pp.571-603. Fourth edition, 1999, pp. 513-536. Fifth edition, 2005, pp. 553-576. AMINOFF MJ, Eisen AA: Sixth edition, 2012, pp. 581-602

14. AMINOFF MJ: Vascular disorders of the spinal cord. In: Handbook of the Spinal Cord, Davidoff RA (Ed), Dekker Publishing Co., 1987, Vol. 4, pp. 259-297.

15. Goodin DS, Shefrin SL, AMINOFF MJ: Electrophysiological correlates of “blind sight” In: Evoked Potentials III: Proceedings of the 3rd International Evoked Potentials Symposium, Barber C, Blum T (Eds), Butterworths: London. 1987. pp. 351-354.

16. Goodin DS, AMINOFF MJ: Electrophysiological distinction between “cortical” and “subcortical” dementias. In: Evoked Potentials III: Proceedings of the 3rd International Evoked Potentials Symposium, Barber C, Blum T (Eds), Butterworths: London. 1987. pp. 154-157.

17. AMINOFF MJ, Cutler JR, Brant-Zawadski M: The sensitivity of MRI scanning and multimodality evoked potentials in the evaluation of patients with suspected multiple sclerosis. In: Evoked Potentials III: Proceedings of the 3rd International Evoked Potentials Symposium, Barber C, Blum T (Eds), Butterworths: London. 1987. pp. 405-407. 34

18. AMINOFF MJ: Angiomas and the Nervous System. In Vascular Birthmarks: Hemangiomas and Malformations, Mulliken J, Young AE (Eds), Saunders: Philadelphia. 1988. pp. 277-300.

19. Gevins AS, AMINOFF MJ: Electroencephalography: Brain electrical activity. In: Encyclopedia of Medical Devices and Instrumentation. Webster JG (Ed), John Wiley & Sons: New York, 1988, pp. 1084-1107.

20. Lowenstein DH, Aminoff MJ: Neurological Disorders. In: Handbook of Medical Treatment, Skach W, Daley C, Forsmark C (Eds). Jones Medical: California, 1988, pp. 445-474.

21. AMINOFF MJ, Katzung BG: Drugs used in Neurology. In: Handbook of Drugs, Katzung BG (Ed). Lange: Los Altos, 1989, pp. 269-293; 2nd edition: Drug Therapy, 1991, pp. 311-336.

22. AMINOFF MJ: Postural Hypotension. In: Neurology and General Medicine, Aminoff MJ (Ed). Churchill Livingstone: New York, First Edition, 1989, pp. 123-143 Second Edition, 1995, pp. 137-158 Third Edition, 2001, pp. 131-150. Fourth edition, 2008, pp. 141-161.

23. AMINOFF MJ: Pregnancy and Disorders of the Nervous System. In: Neurology and General Medicine, Aminoff MJ (Ed). Churchill Livingstone: New York First Edition, 1989, pp. 487-503 Second Edition, 1995, pp. 567-585 Third Edition, 2001, pp. 575-592 Fourth edition, 2008, pp. 673-693.

24. AMINOFF MJ, Edwards MSB: Spinal arteriovenous malformations. In: Cerebrovascular Disease in Childhood and Adolescence, Edwards MSB, Hoffman HJ (Eds). Williams & Wilkins: Baltimore, 1989, pp. 321-335.

25. AMINOFF MJ, Goodin DS: Electrophysiological Features of the Dementia of Parkinson's Disease. In: The 9th International Symposium on Parkinson's Disease, Streifler MB et al (Eds). Raven Press: New York, 1990, pp. 361-363.

26. AMINOFF MJ: Cerebral arteriovenous malformations presenting with seizures. In: Medical Management of Seizures, Resor SR, Kutt H (Eds). Marcel Dekker: New York, 1992, pp. 251-255.

27. AMINOFF MJ: Somatosensory and motor evoked potentials. In: The Spine, Rothman RH, Simeone F (Eds). Saunders: Philadelphia Third Edition, 1992, pp. 172-179. Fourth Edition, 1999, pp 150-157.

28. AMINOFF MJ: Aneurysms and vascular malformations. In: Diseases of the Nervous System: Clinical Neurobiology, 2nd Edition, Asbury AK, McKhann G, McDonald WI (Eds). Saunders: Philadelphia, 1992, pp. 1045-1061.

29. AMINOFF MJ: Spinal vascular disease. In: Diseases of the Spinal Cord, Critchley EMR, Eisen A (Eds). Springer: London, First Edition, 1992, pp. 281-299. Second Edition, 1997, pp. 423-442.

30. Wilbourn AJ, AMINOFF MJ: Radiculopathies. In: Clinical Electromyography, 2nd Edition, Brown WF, Bolton CF (Eds). Butterworths: Boston, 1993, pp. 175-209.

31. AMINOFF MJ: Extrapyramidal disorders. In: Clinical Autonomic Disorders: Evaluation and Management, Low PA (Ed). Little, Brown: Boston, First Edition, 1993, pp. 527-535. 35

Second Edition, 1997, pp. 577-584.

32. Wilbourn AJ, AMINOFF MJ: Role of the electrodiagnostic examination and thermography in the diagnosis of lumbosacral radiculopathy. In: Lumbar Disc Disease, 2nd edition, Hardy RW (Ed). Raven Press: New York, 1993, pp. 81-93.

33. AMINOFF MJ: Electrophysiologic studies of the central and peripheral nervous system. In: Harrison's Textbook of Medicine. McGraw-Hill: New York, Thirteenth Edition, 1994, pp. 2216-2223. Fourteenth Edition, 1998, pp. 2282-2287. Fifteenth Edition, 2001, pp. 2331-2336.

34. AMINOFF MJ: Autonomic Nervous System. In: Neuropsychiatry: A Comprehensive Textbook, Fogel BS, Schiffer RB, Rao SM (Eds). Williams & Wilkins: Baltimore 1st edition, 1996, pp. 93-112. 2nd edition, 2003, pp. 273-293.

35. AMINOFF MJ, Olney RK, So YT: X-linked recessive bulbospinal neuropathy: distinction from other motor neuron diseases. In: Amyotrophic Lateral Sclerosis – from Charcot to the Present and into the Future: Festschrifft for Dr. Forbes Norris, Rose FC (Ed). Smith-Gordon: London, 1994, pp. 31-37.

36. AMINOFF MJ, Olney RK: Clinical neurophysiology of cervical dystonia. In: Therapy with Botulinum Toxin, Jankovic J, Hallett M (Eds). Marcel Dekker: New York, 1994, pp.257-265.

37. AMINOFF MJ: Segmentally specific somatosensory evoked potentials. In: Diagnosis and Management of Disorders of the Spinal Cord. Young RR, Woolsey RM (Eds). WB Saunders: Philadelphia, 1995, pp. 170-176.

38. AMINOFF MJ: Modern concepts of cortical localization. In: An Illustrated History of Brain Function, 2nd Edition. Clarke E, O'Malley CD. Norman Publishing: San Francisco, 1996, pp. 148-175.

39. AMINOFF MJ: Neurological complications of connective tissue diseases and related vasculitides. In: Current Practice of Medicine - Neurology, Koller WC (Ed). Current Medicine: Philadelphia, 1996, pp. 20.2-20.5.

40. AMINOFF MJ, Goodin DS: Cerebral accompaniments and functional significance of the long- latency stretch reflexes in human forearm muscles. In: Neurobiology and Disease: Contributions from Neuroscience to Clinical Neurology, Bostock H, Kirkwood PA, Pullen AH (Eds). Cambridge University Press: Cambridge, 1996, pp. 241-246.

41. AMINOFF MJ: Electroencephalography. In: Principles of Child Neurology, Berg BO (Ed): McGraw-Hill: New York, 1996, pp. 23-38.

42. AMINOFF MJ: Parkinson's disease. In: Geriatric Medicine, Lonergan ET (Ed). Appleton & Lange: Conn, 1996, pp. 253-261.

43. AMINOFF MJ: Neurological consequences of systemic diseases in adults. In: Neurology in Clinical Practice, Bradley WG, Daroff RB, Fenichel GM, Marsden CD (Eds). Butterworth- Heinemann: Boston. Second edition, 1996, pp. 905-930. Third edition, 2000, pp. 1009-1034. Fourth edition, 2004, pp. 1073-1099. Fifth edition, 2008, pp.1041-1066. Sixth edition, 2012, pp. 894-916 (with Josephson, SA)

44. Parent JM, AMINOFF MJ: Treatment of epilepsy in general medical conditions. In: The Treatment of Epilepsy, Shorvon SD, Dreifuss FE, Fish DF, Thomas DGT (Eds). Blackwell: Oxford , 1996, pp. 286-298. 36

Second edition, 2004, pp. 244-254.

45. AMINOFF MJ: Segmentally specific SEPs in the evaluation of back pain. In: Recent Advances in Clinical Neurophysiology: Proceeding of the Tenth International Congress of EMG and Clinical Neurophysiology, Kimura J, Shibasaki H (Eds): Elsevier: Amsterdam 1996, pp. 531-534.

46. AMINOFF MJ: Anoxic, metabolic, and toxic encephalopathies. In: Scientific American Medicine: Dale DC, Federman DD (Eds). Scientific American Medicine: New York, 1996, pp. 11. V11, 1-10. Revised and updated, 1999, pp.11. VII, 1-10 Revised and updated, 2003, pp.11. VII, 1-9 ACP Medicine 2004-2005 edition, pp. 2275-2283 Revised and updated, 2006, for ACPMedicine Online (American College of Physicians). http://acpmedicine.com. February 2006

47. AMINOFF MJ, Parent JM: Comorbidity in adults. In: Epilepsy—A Comprehensive Textbook, Engel JJ, Pedley TA (Eds). Raven Press: New York, 1998, pp. 1957-1970. Second edition, 2008, pp.2007-2019

48. AMINOFF MJ: Parkinson’s disease and other extrapyramidal disorders. In: Harrison’s Textbook of Medicine. McGraw-Hill: New York, 14th edition. 1998, pp. 2356-2363. 15th edition, 2001, pp.2399-2406.

49. Olney RK, AMINOFF MJ: Weakness, myalgias, disorders of movements, and imbalance. In: Harrison’s Textbook of Medicine. McGraw-Hill: New York. 14th edition, 1998, pp. 107-118. 15th edition, 2001, pp. 119-128.

50. AMINOFF MJ: Electrophysiology. In: Textbook of Clinical Neurology, Goetz CG, Pappert EJ (Eds). Saunders: Philadelphia First edition, 1999, pp. 436-457 Second edition, 2003, pp. 465-485 Third edition, 2007, pp. 477-497

51. AMINOFF MJ, Albers JW: Electrophysiologic techniques in the evaluation of patients with suspected neurotoxic disorders. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York, Fourth edition, 1999, pp.721-734 Fifth edition, 2005, pp. 795-811 Sixth edition, 2012, pp. 813-830.

52. Thomas PK, AMINOFF MJ: Neurotoxic effects of workplace exposure. In: Hunter’s Diseases of Occupations, 9th edition, Baxter P, et al (Eds). Arnold: London 2000, pp. 867-880.

53. Koehler PJ, Aminoff MJ: The Brown-Sequard Syndrome. In: Neurological Eponyms, Koehler PJ, Bruyn GW, Pearce JMS. (Eds). Oxford: Oxford University Press, 2000, pp. 200-206.

54. Aminoff MJ: Effects of occupational toxins on the nervous system. In: Neurology In Clinical Practice, Bradley WG, Daroff RB, Fenichel GM, Marsden CD (Eds). Butterworth-Heinemann: Boston Third edition, 2000, pp. 1511-1519 Fourth edition, 2004, pp. 1709-1718 Fifth edition, 2008, pp. 1657-1665.

55. Aminoff MJ: Effects of toxins and physical agents on the nervous system. In: Neurology In Clinical Practice, Bradley WG, Daroff RB, Fenichel GM, Marsden CD (Eds). Butterworth- Heinemann: Boston, Third edition, 2000, pp. 1541-1544 Fourth edition, 2004, pp. 1741-1744 Fifth edition, 2008, pp. 1687-1691 Sixth edition, 2012, pp. 1353-1376

56. Aminoff MJ: Care at the end of life. In: Neurology and General Medicine, Aminoff MJ (Ed). Churchill Livingstone: New York Third edition, 2001. pp. 1069-1075. Fourth edition, 2008, pp. 1199-1207.

57. Parent JM, AMINOFF MJ: Seizures and general medical disorders. In: Neurology and General Medicine, Aminoff MJ (Ed). Churchill Livingstone: New York Third edition, 2001. pp. 967-981. Fourth edition, 2008, pp. 1077-1093.

58. Janavs JL, AMINOFF MJ: Involuntary movements in general medical disorders. In: Neurology and General Medicine, 3rd edition. Aminoff MJ (Ed). Churchill Livingstone: New York, 2001.pp. 983-1002.

59. AMINOFF MJ: EEG monitoring of comatose patients in the intensive care unit. In: Advances in Clinical Neurophysiology, Vol 57, Hallett M, Phillips LH, Schomer DL, Massey JM [Eds]. Elsevier: Amsterdam, 2004, pp 662-666.

60. Griggs RC, Jozefowicz R, AMINOFF MJ: Approach to the patient with neurologic disease. In: Cecil Textbook of Medicine, Goldman L, Ausiello D [Eds]. Elsevier Saunders, Philadelphia 22nd edition, 2004, pp 2196-2205 23rd edition, 2008, pp 2615-2622 24th edition, 2012, pp. 2228-2236

61. AMINOFF MJ: Mechanical and other lesions of the spine, nerve roots, and spinal cord. In: Cecil Textbook of Medicine, Goldman L, Ausiello D [Eds]. Elsevier Saunders, Philadelphia 22nd edition, 2004, pp 2230-2239 23rd edition, 2008, pp 2651-2662

62. AMINOFF MJ: Evaluation of the autonomic nervous system. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York, Fifth edition, 2005, pp. 407-423 Sixth edition, 2012, pp. 455-473

63. Miller TM, AMINOFF MJ: Occupational and use-related mononeuropathies. In: Neurology and Trauma, 2nd edition Evans RW (editor), Oxford, New York, 2006, pp. 376-385.

64. AMINOFF MJ: multiple alphabetically listed entries on neurological topics in 2007 Current Consult Medicine, Papadakis MA, McPhee SJ [Eds]. McGraw-Hill, New York, 2007

65. AMINOFF MJ: Neurological dysfunction and kidney disease. In: Neurology and General Medicine, 4th edition. Aminoff MJ (Ed). Churchill Livingstone: New York, 2008. pp. 327-346.

66. Ralph JW, AMINOFF MJ: Neuromuscular complications of general medical disorders. In: Neurology and General Medicine, 4th edition. Aminoff MJ (Ed). Churchill Livingstone: New York, 2008. pp. 1123-1156.

67. Olney RK, AMINOFF MJ: The neurology of aging. In: Neurology and General Medicine, 4th edition. Aminoff MJ (Ed). Churchill Livingstone: New York, 2008. pp. 1095-1121.

68. Christine CW, AMINOFF MJ: Movement disorders associated with general medical diseases. In: Neurology and General Medicine, Aminoff MJ (Ed). Churchill Livingstone: New York, 2008. pp. 1095-1121.

69. AMINOFF MJ, Lotti M: Neurotoxic effects of workplace exposures. In: Hunter’s Diseases of Occupations,10th edition, Baxter PJ, et al (Eds). Hodder Arnold: London, 2010, pp. 1151-1170

70. AMINOFF MJ: Somatosensory evoked potentials in infants and children. In: Electrodiagnosis in Clinical Neurology, AMINOFF MJ (Ed), Churchill Livingstone: New York, Sixth edition, 2012, pp. 603-614..

ELECTRONIC PUBLICATIONS (excluding electronic versions of print publication)

1. Pocket Medicine/Internal Medicine — Neurology (CD Rom for PDA), 2002.

2. Current Medical Consults: Neurology (Lange-McGraw Hill)

3. Presiding editor and editor-in chief, neurology section, UpToDate (electronic textbook)

OTHER PUBLISHED CONTRIBUTIONS

1. Section Editor, Epitomes of Progress in Neurology (CMA Scientific Advisory Panel on Neurology) for the Western Journal of Medicine, Vol 150, 1989.

2. Participant in development of policy statement by American Academy of Neurology on a. Thermography in Neurologic Practice. Neurology 40:523-525, 1990 b. Intraoperative Neurophysiology. Neurology 40:1644-1646, 1990 c. Clinical Autonomic Testing. Neurology 46:873-880, 1996 d. Dermatomal Somatosensory Evoked Potentials. Neurology 49: 1127-1130, 1997

3. Participant and coauthor in development of reports by American Electroencephalographic Society on a. Guidelines for Writing Clinical Evoked Potential Reports. J Clin Neurophysiol 8:85-87, 1991 b. Guidelines for Clinical Evoked Potential Studies. J Clin Neurophysiol 11: 40-73, 1994

4. Coauthor of reports by the International Federation of Clinical Neurophysiology as follows: a. Nuwer MR, AMINOFF MJ, Desmedt J, et al: IFCN recommended standards for short latency somatosensory evoked potentials. Electroencephalogr Clin Neurophysiol 91:6-11, 1994 b. Nuwer MR, AMINOFF MJ, GOODIN DS, et al: IFCN recommended standards or brain-stem auditory evoked potentials. Electroencephalogr Clin Neurophysiol 91:12- 17, 1994. c. Pratt H, AMINOFF M, Nuwer MR, Starr A: Short-latency auditory evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 52:69-77, 1999 d. Cruccu G, AMINOFF MJ, Curio G, et al: Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119:1705-1719, 2008

5. Reviewer of draft on neurology for the 1995/6 revision of the AMA Manual of Style and the 2004/5 revision.

6. Coauthor of report for American Association of Electrodiagnostic Medicine 39

a. Kraft GM, AMINOFF MJ, Baran EM, et al: Somatosensory evoked potentials: clinical uses. Muscle Nerve 21:252-258, 1998.

7. Participant in and co-author of development of “An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines,” edited by Olanow CW, Koller WC. Neurology 50: Supplement 3, 1998

8. Participant in and co-author of an issue of Continuum, published by the American Academy of Neurology, on Clinical Neurotoxicology. Continuum 5, No. 1, 1999 (entire issue)

CORRESPONDENCE

1. AMINOFF MJ: Bell's palsy and pregnancy. Lancet 2:796, 1973

2. AMINOFF MJ, Marshall J, Smith EM, Wyke MA: Cognitive function in patients on lithium therapy. Br J Psychiatry 125:109-110, 1974

3. AMINOFF MJ: Subarachnoid hemorrhage secondary to spinal arteriovenous malformation and aneurysm. Arch Neurol 38:67, 1981

4. AMINOFF MJ, Beckley DJ, McIlroy MB: Autonomic function in myotonic dystrophy. Arch Neurol 42:16, 1985

5. AMINOFF MJ, Goodin DS: Treatment of Parkinson's disease with Ciladopa. Reply to letter by S.R. Snider. Ann Neurol 22:558, 1987

6. AMINOFF MJ: Management of cerebral arteriovenous malformations. Reply to Drs. Spetzler and Luessenhop. Neurology 38:169, 1988

7. Goodin DS, AMINOFF MJ: Parkinson's disease and Ciladopa. Neurology 38:167, 1988

8. AMINOFF MJ, Goodin DS: Dermatomal somatosensory evoked potentials in lumbosacral root compression. J Neurol Neurosurg Psychiatry 51:740-741, 1988

9. AMINOFF MJ, So YT, Olney RK: Thermography. Neurology 39:1004-1005, 1989

10. AMINOFF MJ: Botulinum toxin therapy for torticollis. West J Med 150:569, 1989

11. AMINOFF MJ, Olney RK: Electrodiagnosis of brachial plexopathies. Neurology 39:1137, 1989

12. Gelb DJ, Lowenstein DH, AMINOFF MJ: Botulinum toxin in torticollis. Neurology 39:1404, 1989

13. AMINOFF MJ, So YT, Olney RK: Thermography. Neurology 40:561-563, 1990

14. Goodin DS, AMINOFF MJ, Laxer KD: Multiple electroencephalographic electrodes for spike detections in partial complex seizures. Ann Neurol 29:224-225, 1991

15. So YT, AMINOFF MJ, Olney RK: Comparison of thermography and electromyography: a reply. Muscle Nerve 14:787, 1991

16. Goodin DS, AMINOFF MJ: Readiness potential. Neurology 44:2213, 1994

17. AMINOFF MJ: Practice parameters. Neurology 45: 1946, 1995

18. Garcia PA, AMINOFF MJ, Goodin DS: N30 in PD. Neurology 47:303-306, 1996

19. Scott WK, Stajich JM, Yamaoka LH, Speer MC, Vance JM, Roses AD, Pericak-Vance MA, Deane Laboratory Parkinson Disease Research Group (AMINOFF MJ et al). Genetic complexity and Parkinson’s disease. Science 277:387-388, 1997

20. AMINOFF MJ: Median-innervated intrinsic hand muscles. Ann Thorac Surg 69: 666, 2000

21. Nichols WC, Pankratz N, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally PM, Foroud T, and the Parkinson Study Group (AMINOFF MJ et al): Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families. J Med Genet 39: 489-492, 2002

BOOK REVIEWS

1. AMINOFF MJ: Review -- Neurology of Pregnancy, by JD Donaldson. Neurology 28:1080-1081, 1978

2. AMINOFF MJ: Review -- EEG and Clinical Neurophysiology, by H Lechner, A Aranibar. Trends in Neurosciences 4:XVII, 1981

3. AMINOFF MJ: Review -- Experimental Therapeutics of Movement Disorders, by S Fahn, DB Calne, I Shoulson (Eds). Neurology 34:137-138, 1984

4. AMINOFF MJ: Review -- Epilepsy. Diagnosis, Management, Quality of Life, by JK Penry. J Neurosurg 67:144, 1987.

5. AMINOFF MJ: Review -- Manual of Nerve Conduction Velocity and Somatosensory Evoked Potentials (2nd Edition), by JA Delisa, EM Baran. Am J EEG Technol 27:170-171, 1987

6. AMINOFF MJ: Review--Intracranial Vascular Malformations, by DH Barrow (Ed). Neurology 41:769, 1991

7. AMINOFF MJ: Review--Alcohol and Seizures, by RJ Porter, RH Maltson, JA Cramer, I Diamond (Eds). J Clin Neurophysiol 8:243,1991

8. AMINOFF MJ: Review--New Trends and Advanced Techniques in Clinical Neurophysiology, by PM Rossini, F Mauguiere (Eds). J Clin Neurophysiol 9:316, 1992

9. AMINOFF MJ: Review--Peripheral Neurology: Case Studies in Electrodiagnosis (2nd Edition), by JA Liveson. J Clin Neurophysiol 9:161-162, 1993

10. AMINOFF MJ: Review--Parkinson's Disease from Basic Research to Treatment, by H. Narabayashi, Y. Nagatsu, N. Yanagisawa, Y. Mizuno (Eds). Ann Neurol 34:118, 1993

11. AMINOFF MJ: Review -- Parkinson's Disease: Neurobehavioral Aspects, by SJ Huber, JL Cummings (Eds). N Engl J Med 328:1720-1721, 1993

12. AMINOFF MJ: Review--Neurological Complications of Pregnancy, by O Devinsky, E Feldmann, B Hainline (Eds). Ann Neurol 36:119;1994

13. AMINOFF MJ: Review--Dural Arteriovenous Malformations and Cavernous Malformations, by JA Awad, D.L. Barrow (Eds) Neurology 44:2222, 1994

14. AMINOFF MJ: Review -- Neurology: Problems in Primary Care, 2nd edition, by JL Bernat, FM Vincent. Ann Intern Med 121:157,1994

15. AMINOFF MJ: Review -- Brain’s Diseases of the Nervous System, 10th edition, by JN Walton (Ed). JAMA 272:1627-1628, 1994

16. AMINOFF MJ: Review -- Neurologic Skills: Examination and Diagnosis, by TH Click. Ann Intern Med 120:815,1994

17. AMINOFF MJ: Review--The Headaches, by J Olesen, P Tfelt-Hansen, KMA Welch (Eds). J Clin Neurophysiol 12:100, 1995

18. AMINOFF MJ: Review -- Handbook of Dystonia, by JKC Tsui, DB Calne (Eds). Ann Neurol 38:484, 1995

19. AMINOFF MJ: Review -- Clinical Neurophysiology, by JR Daube (Ed). Ann Neurol 39:688,1996

20. AMINOFF MJ: Review -- The Babinski Sign: A Centenary, by J van Gijn. Ann Neurol 40:132, 1996

21. AMINOFF MJ: Review -- Charcot: Constructing Neurology, by CG Goetz, M Bonduelle, T Gelfand. Ann Neurol 40:131-132, 1996

22. AMINOFF MJ: Review -- Office Practice of Neurology, by MA Samuels, S Feske (Eds). N Engl J Med 335:903-904, 1996

23. AMINOFF MJ: Review -- Principles of Neurology, 6th edition, by RD Adams, M Victor, AH Ropper. JAMA 277:1817-1818, 1997

24 AMINOFF MJ: Review -- Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management, by MD Ginsberg, J Bougousslavsky JAMA 280:2129, 1998

25 AMINOFF MJ: Review -- Publishing Your Own Medical Research Paper, by DW Byrne. Muscle Nerve 22:550, 1999

26 AMINOFF MJ: Review -- John Hughlings Jackson: Father of English Neurology, by M Critchley, EA Critchley. 42

Electroencephalogr Clin Neurophysiol 110:782, 1999

27 AMINOFF MJ: Review -- Goldensohn's EEG Interpretation, 2nd edition, by ES Goldensohn, AD Legatt, S Koszer, SM Wolf. Arch Neurol 56: 1298, 1999

28 AMINOFF MJ: Review: -- Comprehensive Neurology, 2nd edition, by RN Rosenberg, DE Pleasure (Eds) Muscle Nerve 22:293, 1999

29 AMINOFF MJ: Review --Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects, 2nd edition, by Chokroverty S (Ed) Muscle Nerve 23:442, 2000

30 AMINOFF MJ: Review -- Autonomic Failure:A Textbook of Clinical Disorders of the Autonomic Nervous System,4th edition, by Mathias CJ, Bannister R (Eds). J Neurol 415:891, 2000

31 AMINOFF MJ: Review -- Experimental and Clinical Neurotoxicology, 2nd edition, by Spencer PS, Schaumburg HH (Eds). Muscle Nerve 23: 1897, 2000

32 AMINOFF MJ: Review --Principles of Neural Science, 4th edition, by Kandel ER, Schwartz JH, Jessell TM (Eds). Muscle Nerve 24: 839, 2001

33 AMINOFF MJ: Review-- Aids to the Examination of the Peripheral Nervous System, 4th edition, for the Guarantors of Brain. Muscle Nerve 24: 975, 2001

34 AMINOFF MJ: Review -- Brain's Diseases of the Nervous Sustem, 11th edition, by Donaghy M (Ed) JAMA 287:1053, 2002

35. AMINOFF MJ: Review -- Clinical Cases in Neurology, by Schapira AHV, Rowland LP (Eds). Muscle Nerve 25:126, 2002

ABSTRACTS

1. AMINOFF MJ, Sears TA: Segmental integration of converging input to thoracic respiratory motoneurones. J Physiol (Lond) 208:76, 1970

2. Sears TA, AMINOFF MJ: Spinal integration of cortical, brainstem and segmental inputs to thoracic respiratory motoneurones. Neurology 20:383, 1970

3. AMINOFF MJ, Wilcox CS: The control of blood pressure in Parkinsonism. Proc R Soc Med 65:944-946, 1972

4. Wilcox CS, AMINOFF MJ, Kurtz AB, Slater JDH: Deficient renin release in autonomic insufficiency corrected by dopamine infusions or orthostasis during sodium deficiency. Excerpta Medica Int Congr Series 256:581, 1972

5. AMINOFF MJ, Millar JGB, Wilcox CS, Keenan J: Monoamines et secretion de corticotrophine. Rev Neurol (Paris) 127:301, 1972 43

6. AMINOFF MJ, Wilcox CS, Slater JDH: Autonomic defects in paralysis agitans and in the Shy-Drager syndrome. Acta Neurol Scand suppl 5:105-107, 1972

7. AMINOFF MJ, Wilcox CS, Slater JDH, Kremer M: Blood pressure, sodium conservation and plasma renin in patients with Parkinsonism. Q J Med 41:540, 1972

8. Wilcox CS, AMINOFF MJ, Keenan J, Millar JGB, Kremer M: The effect of intravenous catecholamines on circulating levels of growth hormone, corticotrophin and cortisol in man. J Endocrinol 58:VI, 1973

9. AMINOFF MJ, Gross M: A study of vasomotor function in patients with Huntington's chorea. Clin Sci 45:20P, 1973

10. Millar JGB, Kurtz A, AMINOFF MJ, Wilcox CS, Nabarro JDN: L-dopa as a test of anterior pituitary function. J Endocrinol 59:XXV-XXVI, 1973

11. AMINOFF MJ, Wilcox CS, Kremer M, Slater JDH: Plasma renin and pressor responses to intravenous catecholamine infusion in normal subjects and in patients with Parkinson's disease or in the Shy-Drager syndrome. Clin Sci Mol Med 46:25P, 1974

12. AMINOFF MJ, Jaffe RA, Vidruk E, Sampson SR: Analysis of dopamine inhibition of carotid body chemoreceptors in cats. Pharmacologist 17:257, 1975

13. Sampson SR, AMINOFF MJ, Jaffe RA, Vidruk EH: Dopamine mediation of neurally- evoked inhibition of carotid body chemoreceptors in cats. Physiologist 18:375, 1975

14. AMINOFF MJ, Layzer RB, Satya-Murti S, Faden AI: The declining muscle response to repetitive nerve stimulation in myotonia. Neurology 26:368, 1976

15. AMINOFF MJ, Jaffe RA, Vidruk EH, Samson SR: The effects of droperidol on chemoreceptor activity in cats. Pharmacologist 19:188, 1977

16. Ochs AL, AMINOFF MJ: Effect of adaptation to the stimulating pattern on the latency and waveform of visual evoked potentials. Clin Res 27:52A, 1979

17. Stahl SM, Layzer RB, AMINOFF MJ, Feldon S: Continuous cataplexy in a patient with a midbrain tumor: the limp-man syndrome. Neurology 29:540-541, 1979

18. Asher SW, AMINOFF MJ: Tetrabenazine: an effective means of treating selected movement disorders. Neurology 30:383, 1980

19. Simon RP, AMINOFF MJ: Clinical aspects of status epilepticus in an unselected urban population. Ann Neurol 8:93, 1980 Trans Am Neurol Assoc 105:46-49, 1980

20. AMINOFF MJ, Simon RP: Clinical aspects of status epilepticus in an unselected urban population. 44

Acta Neurol Scand suppl 79:78-79, 1980

21. Ochs AL, AMINOFF MJ: Pattern-reversal and pattern-onset visual evoked potentials in normal subjects and patients with possible multiple sclerosis. Electroencephalogr Clin Neurophysiol 51:27P, 1981

22. AMINOFF MJ, Greenberg DA, Weinkle DJ: Periodic EEG complexes in infectious mononucleosis encephalitis. Electroencephalogr Clin Neurophysiol 53:28P, 1982

23. AMINOFF MJ, Simon RP: Hormonal responses to a single generalized seizure. In: Abstracts, 14th Epilepsy International Symposium, 1982

24. Simon RP, AMINOFF MJ, Benowitz NL: Plasma catecholamine concentrations following generalized seizures. In: Abstracts, 14th Epilepsy International Symposium, 1982

25. Simon RP, AMINOFF MJ, Benowitz NL: Changes in plasma epinephrine and norepinephrine concentrations following generalized tonic-clonic seizures in humans. Ann Neurol 12:93, 1982

26. AMINOFF MJ, Simon RP: Endocrinological changes following a single generalized seizure in humans. Ann Neurol 12:93, 1982

27. Lukes SA, AMINOFF MJ, Mills C, Norman D, Crooks L, Panitch HS: Nuclear magnetic resonance imaging in patients with definite multiple sclerosis. Ann Neurol 12:76, 1982

28. Lukes SA, AMINOFF MJ, Mills C, Norman D, Newton TH: Comparison of nuclear magnetic resonance and computed tomographic findings in patients with extra-pyramidal movement disorders. Ann Neurol 12:88, 1982

29. Lotti M, Becker CE, AMINOFF MJ, Woodrow JE, Seiber JN, Talcott RE, Richardson RJ: Occupational exposure to a neurotoxic organophosphate: monitoring lymphocyte neurotoxic esterase. Vet Hum Toxicol 24:220-221, 1982

30. Davis SL, AMINOFF MJ, Panitch HS: Serial somatosensory evoked potentials in multiple sclerosis: limited correlation with clinical disease activity. Ann Neurol 14:147, 1983

31. Goodin DS, Waltz DA, AMINOFF MJ: Task specific asymmetries in the event-related potential to language stimuli. Electroencephalogr Clin Neurophysiol 57:62P, 1984

32. Goodin DS, AMINOFF MJ: Relationship of the event-related potential to the timing of a motor response. Electroencephalogr Clin Neurophysiol 57:62P, 1984

33. AMINOFF MJ, Goodin DS, Barbaro NM, Rosenblum ML: Dermatomal somatosensory evoked potentials in the evaluation of patients with lumbosacral radiculopathies. Neurology 34[Suppl 1]:142, 1984

34. Wilcox CS, Puritz R, Lightman SL, Bannister R, AMINOFF MJ: Plasma volume and blood pressure in progressive autonomic failure: effects of salt intake and posture. Clinical Res 32:217A, 1984

35. Davis SL, AMINOFF MJ, Berg BO: Brainstem auditory evoked potentials in children with brainstem or cerebellar dysfunction. Electroencephalogr Clin Neurophysiol 58:56P-57P, 1984 45

36. Goodin DS, Waltz DA, AMINOFF MJ: Electrophysiologic evidence for hemispheric specialization in cognitive function. Electroencephalogr Clin Neurophysiol 58:47P, 1984

37. Goodin DS, AMINOFF MJ: Relationship of motor and cerebral responses to an auditory stimulus. Electroencephalogr Clin Neurophysiol 58:47P, 1984

38. Goodin DS, AMINOFF MJ, Mantle MM: Evoked cerebral potentials and voluntary motor activity. Muscle Nerve 7:584, 1984 Electroencephalogr Clin Neurophysiol 62:3P, 1985

39. AMINOFF MJ, Goodin DS, Parry GJ, Rosenblum ML, Barbaro NM, Weinstein PR: Electrophysiologic evaluation of lumbosacral radiculopathies. Muscle Nerve 7:582, 1984 Electroencephalogr Clin Neurophysiol 62:1P, 1985

40. Simon RP, AMINOFF MJ: An unusual EEG finding in patients with post-anoxic coma. Electroencephalogr Clin Neurophysiol 61:S38, 1985

41. AMINOFF MJ, Goodin DS: Comparison of diagnostic yield of EEG and P3 in patients with dementia. Electroencephalogr Clin Neurophysiol 61:S46, 1985

42. Goodin DS, AMINOFF MJ, Mantle MM: The influence of task complexity on the relationship between evoked cerebral potentials and voluntary movement. Electroencephalogr Clin Neurophysiol 61:S77, 1985

43. Goodin DS, AMINOFF MJ, Mantle MM: Response-locked and stimulus-locked components of the event-related potential. Electroencephalogr Clin Neurophysiol 61:S170, 1985

44. Berg BO, AMINOFF MJ, Goodin DS: Ambulatory EEG monitoring in children. Abstracts, 16th Epilepsy International Congress, 1985

45. AMINOFF MJ, Goodin DS: Evaluation of demented patients by electroencephalography and P300 response. Neurology 36[Suppl 1]:267, 1986

46. Goodin DS, AMINOFF MJ: Evoked potential findings in different categories of dementia. Neurology 36[Suppl 1]:268, 1986

47. AMINOFF MJ, Parry GJ: Somatosensory evoked potentials in chronic demyelinating neuropathy with absent sensory nerve action potentials. Neurology 36[Suppl 1]:155-156, 1986

48. Cutler JR, AMINOFF MJ, Brant-Zawadski M: Comparative value of MRI and evoked potential studies in multiple sclerosis. Neurology 36[Suppl 1]:156, 1986

49. AMINOFF MJ, Simon RP, Wiedemann E: Interictal generalized epileptiform EEG discharges and plasma prolactin levels. Neurology 36[Suppl 1]:128, 1986

50. Simon RP, AMINOFF MJ: A clinical sign predicting electroencephalographic status epilepticus in anoxic coma. Neurology 36[Suppl 1]:287, 1986

51. Goodin DS, AMINOFF MJ: The distinction between different types of dementia using evoked potentials. In: Eighth International Conference on Event-Related Potentials of the Brain: Research Reports. Rohrbaugh JW, Johnson R, Parasuraman R (Eds), 1986, pp. 90-92.

52. Shefrin SL, Goodin DS, AMINOFF MJ: Electrophysiological evidence of visual processing in a blind field. In: Eighth International Conference on Event-Related Potentials of the Brain: Research Reports. Rohrbaugh JW, Johnson R, Parasuraman R (Eds), 1986, pp. 131-133.

53. Cutler JR, AMINOFF MJ, Brant-Zawadski MN: Comparison of magnetic resonance imaging and evoked potential findings in patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol 64:31P, 1986

54. Goodin DS, AMINOFF MJ: Long-latency evoked potential findings in demented and nondemented patients with Parkinson's disease. Ann Neurol 20:127, 1986

55. AMINOFF MJ, Goodin DS, Berg BO, Compton MN: Role of ambulatory EEG recordings in epileptic and nonepileptic children. J Clin Neurophysiol 4:210, 1987 Electroencephalogr Clin Neurophysiol 69:81P, 1988

56. AMINOFF MJ, Olney RK, Parry GJ, Raskin NH: Somatosensory evoked potentials in suspected brachial plexopathy. J Clin Neurophysiol 4:216, 1987 Electroencephalogr Clin Neurophysiol 69:82P, 1988

57. Goodin DS, Shefrin SL, AMINOFF MJ: The phenomenon of “blindsight”: Its investigation by evoked potentials. Neurology 37[Suppl 1]:361, 1987

58. Lowenstein DH, AMINOFF MJ, Simon RP: A prospective study of pentobarbital coma for refractory status epilepticus. Neurology 37[Suppl 1]:351, 1987

59. Lowenstein DH, AMINOFF MJ: The clinical course of spasmodic torticollis. Neurology 37[Suppl 1]:123, 1987

60. AMINOFF MJ, Olney RK, Parry GJ, Raskin NH: Electrophysiological evaluation of brachial plexopathy: clinical relevance. Ann Neurol 22:165, 1987

61. AMINOFF MJ, Goodin DS, Berg BO, Compton MN: Clinical relevance of ambulatory electroencephalographic recording in 95 epileptic and nonepileptic children. Ann Neurol 22:130, 1987

62. AMINOFF MJ: Clinical uses of dermatomal somatosensory evoked potentials. Electroencephalogr Clin Neurophysiol 66:S2, 1987

63. Olney RK, AMINOFF MJ, Gelb DJ, Lowenstein DH: Neuromuscular effects distant from botulinum toxin injections. Neurology 38[Suppl 1]:217, 1988

64. Gelb DJ, Lowenstein DH, AMINOFF MJ: Botulinum toxin in the treatment of spasmodic torticollis. Neurology 38[Suppl 1]:244, 1988

65. AMINOFF MJ, Scheinman MM, Griffin JC, Herre JM: Neurophysiologic accompaniments of ventricular arrhythmias producing syncope. J Am Coll Cardiol 11[Suppl A]:7A, 1988

66. So YT, AMINOFF MJ, Olney RK: Clinical utility of thermography in patients with lumbosacral radiculopathy. Neurology 39[Suppl 1]:376, 1989

67. So YT, Olney RK, AMINOFF MJ: Evaluation of thermography in diagnosis of carpal tunnel syndrome. Neurology 39[Suppl 1]:376, 1989

68. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, AMINOFF MJ: Changes in pattern of muscle activity following botulinum toxin injections for torticollis. Neurology 39[Suppl 1]:320, 1989

69. Olney RK, AMINOFF MJ: Diagnostic sensitivity of different electrophysiologic techniques in Guillain-Barre syndrome. Neurology 39[Suppl 1]:354, 1989

70. Olney RK, AMINOFF MJ, So YT: Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy. Neurology 39[Suppl 1]:400, 1989

71. Lowenstein DH, Simon RP, AMINOFF MJ: Clinical and electroencephalographic correlates of status epilepticus. Neurology 39[Suppl 1]:114, 1989

72. Goodin DS, AMINOFF MJ, Laxer KD: Comparative utility of different electroencephalographic recording montages for detecting epileptiform activity. J Clin Neurophysiol 6:345, 1989

73. So YT, Olney RK, AMINOFF MJ: A critical evaluation of thermography in the diagnosis of cervical radiculopathy. Muscle Nerve 12:777, 1989

74. Olney RK, So YT, Goodin DS, AMINOFF MJ: A comparison of magnetic and electric stimulation of peripheral nerves. Muscle Nerve 12:750, 1989

75. Goodin DS, AMINOFF MJ, Shih PY: Somatosensory evoked potential correlates of the long- latency stretch responses. Electroencephalogr Clin Neurophysiol 72:97P, 1989

76. Olney RK, AMINOFF MJ: Electrodiagnostic features of the Guillain-Barré syndrome: the relative sensitivity of different techniques. Electroencephalogr Clin Neurophysiol 75:S111, 1990

77. Goodin DS, AMINOFF MJ, Chernoff DN, Hollander H: HIV encephalopathy: an investigation using cerebral evoked potentials. Neurology 40[Suppl 1]:162, 1990

78. Yoshimura DM, AMINOFF MJ, Tami TA: Botulinum toxin therapy for hemifacial spasm. Neurology 40[Suppl 1]:381, 1990

79. Olney RK, So YT, Goodin DS, AMINOFF MJ: Facilitation of the soleus H reflex by magnetic brain stimulation. Neurology 40[Suppl 1]:216, 1990

80. Yoshimura D, AMINOFF MJ: Long-term follow-up of patients treated with botulinum toxin for spasmodic torticollis. Movement Disorders 5[Suppl 1]:75, 1990

81. AMINOFF MJ: Clinical neurophysiology of HIV infection. 48

Electroencephalogr Clin Neurophysiol 75:S3, 1990

82. Goodin DS, AMINOFF MJ, Chernoff DN, Hollander H: Event-related potentials in HIV infection. Electroencephalogr Clin Neurophysiol 75:S51, 1990

83. Yoshimura D, AMINOFF MJ, Olney RK: Botulinum toxin therapy of limb dystonia. Neurology 41[Suppl 1]:291, 1991

84. AMINOFF MJ, Goodin DS, Chequer RS: Functional roles of the late reflex muscle activity. J Clin Neurophysiol 10:240, 1993

85. Olney RK, So YT, Goodin DS, AMINOFF MJ: The effect of magnetic brain stimulation on the H reflex. J Clin Neurophysiol 10:244, 1993

86. Goodin DS, AMINOFF MJ, Ortiz TA: Event related potentials in a three-choice reaction time task. J Clin Neurophysiol 10:242, 1993

87. AMINOFF MJ, Goodin DS, Ortiz TA: Premovement cerebral potentials in simple reaction-time tasks. Neurology 43 [Suppl 2]: A268, 1993

88. Goodin DS, AMINOFF MJ, Ortiz TA: Anticipatory cerebral events in a three-choice reaction- time task. Neurology 43 [Suppl 2]: A157, 1993

89. Stolov WC, AMINOFF MJ, Caruso G: Evaluation of spinal roots. Electroencephalogr Clin Neurophysiol 87:518, 1993

90. Maeztu MC, Goodin DS, AMINOFF MJ: Effect of age on late EMG activity following muscle stretch. Neurology 44 [Suppl 2]: A203, 1994

91. Goodin DS, AMINOFF MJ, Ortiz T: Preparatory cerebral potentials in three-choice reaction- time tasks. J Clin Neurophysiol 11:255, 1994.

92. AMINOFF MJ, Goodin DS, Ortiz T: Cerebral potentials preceding movement in simple reaction-time tasks. J Clin Neurophysiol 11:261-262, 1994

93. Garcia PA, AMINOFF MJ, Goodin DS: The frontal N30 component of the median derived SEP in patients with predominantly unilateral Parkinson’s disease. Electroencephalogr Clin Neurophysiol 91:61P, 1994

94. AMINOFF MJ, Goodin DS: Electrophysiological characterization of the dementia in Parkinson's disease. Behav Neurol 7:5-6, 1994

95. Goodin DS, AMINOFF MJ: Non-random variability in a reaction-time time series. Neurology 45 [Suppl 4]: A212, 1995

96. Goodin DS, AMINOFF MJ: The non-random variability of reaction times. Electroencephalogr Clin Neurophysiol 95: 15P, 1995

97. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Roberts TP: Comparison of EEG and MEG recorded event-related potentials. J Clin Neurophysiol 12:515, 1995

98. Knowlton R, Roberts T, AMINOFF M, Goodin D, Rowley H: Localization of visual evoked cortical activation with multichannel magnetoencephalography. J Clin Neurophysiol 12:523, 1995

99. Jobst EE, Melnick ME, Byl NN, Dowling GA, AMINOFF MJ: A comparison of sensory perception between patients with Parkinson’s disease (PD) and matched controls. Soc Neurosci Abstracts 21:1250, 1995

100. AMINOFF MJ: Segmentally specific SEPs in the evaluation of back pain. Electroencephalogr Clin Neurophysiol 97:S43, 1995

101. Siedenberg R, Goodin DS, AMINOFF MJ: Changes of forearm EMG and cerebral evoked potentials following sudden muscle stretch during isometric contractions in patients with Parkinson’s disease. Neurology 46:Suppl, A391, 1996

102. Melnick ME, Wallace LW, Dowling GA, AMINOFF MJ, Byl NN: Sensory processing and postural stability. Neurology 46:Suppl, A130, 1996

103. Dowling GA, Melnick ME, Wallace LW, AMINOFF MJ, Byl NN: Progression of postural instability in patients with Parkinson’s disease. Neurology 46:Suppl, A130, 1996

104. AMINOFF MJ, Bolla K, Goetz CG: Acute/subacute peripheral neuropathy and dioxin (Agent Orange). Neurology 46:Suppl, A283-A284, 1996

105. Nakajima M, Eisen A, Entezari-Taher M, Stewart H, Sorensen T, AMINOFF M, Olney R: Spinal motoneurons in amyotrophic lateral sclerosis are differentially excitable to peripheral and cortical stimuli. Neurology 46:Suppl, A472, 1996

106. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Poeppel D, Roberts TPL: Sensory and cognitive components of auditory evoked electrical potentials and auditory evoked magnetic fields. Abstract Book, Third Annual Meeting, Cognitive Neuroscience Society, p. 16, 1996

107. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Roberts TPL: Localizing dipoles: the correlation coefficient and the goodness of fit in source localization of filtered noise. Biomag96: The Tenth International Conference on Biomagnetism, p., 158, 1996

108. Siedenberg R, Goodin DS, AMINOFF MJ, Rowley HA, Roberts TPL: Equivalent current dipole solutions: can the correlation coefficient and the goodness of fit distinguish between signal and noise? J Clin Neurophysiol 13: 450, 1996 Electroencephalogr Clin Neurophysiol 103: 37P, 1997

109. Siedenberg R, Goodin DS, AMINOFF MJ: Changes of forearm EMG and cerebral evoked potentials following sudden muscle stretch in patients with Huntington’s disease. J Clin Neurophysiol 13: 450, 1996 Electroencephalogr Clin Neurophysiol 103: 36P-37P, 1997

110. Siedenberg R, AMINOFF MJ, Goodin DS: Muscle and cerebral responses to predictable and unpredictable wrist displacement in patients with Parkinson’s disease. Mov Disord 12:17, 1997

111. Assaf BA, Laxer KD, Knowlton RC, Garcia PA, Marks WJ, Bernath O, Barbaro NM, AMINOFF MJ, Rowley HA: Magnetoencphalography In epilepsy after craniotomy. Epilepsia 38:Suppl 8, 63, 1997

112. Assaf BA, Knowlton RC, Garcia PA, Laxer KD, AMINOFF MJ, Rowley HA: lctal and interical MEG in extratemporal lobe epilepsy. Epilepsia 38:Suppl 8, 157, 1997

113. Dowling GA, AMINOFF MJ: Melatonin for treatment of sleep disturbances in Parkinson’s disease. Neurology 50:Suppl, A82, 1998

114. Scott WK, Yamaoka LH, Stajich JM, Speer MC, Scott BL, Nance M, Hubble J, Watts RL, Koller W, Jankovic J, Ondo W, Stern MB, Colcher A, Hiner BC, Allen FH, Goetz G, Pappert E, Mastaglia F, Laing NG, Small GW, Masterman D, Haines JL, Davis T, AMINOFF M, Dowling G, Vance JM, Roses AD, Pericak-Vance MA: Exclusion of the α-synuclein gene as a major genetic risk factor in idiopathic Parkinson’s disease (PD). Neurology 50:Suppl, A356-A357, 1998

115. Marks W, Christine C, Clay H, Heath S, AMINOFF M, Starr P: Unilateral and bilateral deep brain stimulation of the globus pallidus or subthalamic nucleus in patients with medically refractory Parkinson's disease: short-term results from a randomized study. Mov Disord 15:Suppl 3, 53, 2000

116. Gottwald MD, Dowling GA, DiMinno M, Poff D, Dozier DM, Krulewicz SP, AMINOFF MJ: The replacement of pergolide with ropinirole: a dose substitution study. Mov Disord 15: Suppl 3, 109, 2000

117. Parkinson Study Group: A controlled trial of rasagiline in early Parkinson's disease. Ann Neurol 48: 489, 2000

118. Kieburtz K, Parkinson Study Group: Efficacy and safety of rasagiline as monotherapy in early Parkinson's disease. Parkinsonism Rel Disord 7 (Suppl): 200, 2001

119. Dowling GA, AMINOFF MJ, Mastick J: Subjective appraisal of daytime sleepiness in Parkinson’s disease: a comparison of three scales. Mov Disord 17: S110, 2002

120. Dowling GA, AMINOFF MJ, Mastick J, et al: The effect of melatonin treatment on sleep and sleepiness in dopamine agonist treated patients with Parkinson’s disease. Mov Disord 17: S102, 2002

121. Dowling GA, AMINOFF MJ, Mastick J, et al: Subjective appraisal of daytime sleepiness in patients with Parkinson’s disease using ergot or nonergot dopamine agonists. Mov Disord 17: S90, 2002

122. Dowling GA, Mastick J, Colling E, Carter J, AMINOFF M: Actigraphic assessment of the effects of melatonin treatment on nighttime sleep in patients with Parkinson’s disease. Sleep 26: Abstracts Suppl, A331, 2003

123. Dowling GA, Mastick J, AMINOFF MJ, Colling E, Carter JH, Singer CM: Melatonin treatment for sleep-related symptoms in patients with Parkinson’s disease. Mov Disord 20: Suppl 10: S130-131, 2005

124. Eberling JL, Bankiewicz KS, McGuire D, AMINOFF M, Christine C, Starr P, Larson P, Jagust WJ: Early results from a clinical trial of AADC gene therapy for Parkinson’s disease. Neurology 66: Suppl 2: A276-277, 2006

125. Christine CW, Starr PA, Larson P, Mah R, Eberling J, Jagust W, McGuire D, AMINOFF MJ: Aromatic L-amino acid decarboxylase gene transfer therapy for Parkinson’s disease: initial results of an open-label, dose escalation, safety and tolerability study. Neurology 66: Suppl 2: A185, 2006

126. Christine CW, Starr PA, Larson P, Mah R, Eberling J, Jagust W, AMINOFF MJ. Aromatic L-amino acid decarboxylase gene transfer therapy for Parkinson’s disease: initial results of an open-label, dose escalation, safety and tolerability study. Mov Disord 21: Suppl 15: S399, 2006

127. Schwid SR for the PRESTO and LARGO investigators (AMINOFF MJ, principal site investigator): Once-daily rasagiline produces consistent treatment benefits in U.S. and European studies of PD patients. Ann Neurol 60: S24-125, 2006

128. AMINOFF MJ: EEG monitoring of ICU patients. Clin Neurophysiol 117: (Suppl 1):S16-S17, 2006

129. AMINOFF MJ: Neurological complications of diabetes:small-fiber neuropathy. Clin Neurophysiol 117: (Suppl 1):S38, 2006

130. AMINOFF MJ, Christine CW, Bankiewicz K, Starr PA, Larson P, Mah R, Eberling JL, Jagust WJ: Preliminary results of an open-label, dose-escalation, safety study of AADC gene transfer therapy for Parkinson’s disease. Mov Disord 22: Suppl 16: S126, 2007

131. Bankiewicz KS,Valles F, Starr PA, Larson, PS, Christine CW, Fiandaca MS, Jagust WJ, Hawkins RA, Forsayeth J, AMINOFF MJ, Eberling JL. Imaging of AAV2-hAADC infusion in a Phase I study of AAV2-hAADC gene therapy for Parkinson's disease. Mov Disord 24 (Suppl 1):S157-158, 2009

132. AMINOFF MJ, Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA,VanBrocklin HF, Bankiewicz KS. Intraputaminal AADC gene therapy for Parkinson's disease: Results of a Phase 1 Study. Mov Disord 24 (Suppl 1):S254-255, 2009

133. Hess CP, Christine CW, Charlton NN, Van Morze C, Dillon WP, AMINOFF MJ: Directional diffusion parameters help differentiate progressive supranuclear palsy, corticobasal syndrome, and Parkinson’s disease. Ann Neurol 68:(suppl 14) S21, 2010

134. Christine CW, AMINOFF, MJ, et al Identification of axonal transport biomarkers in Parkinson’s disease. Ann Neurol 72:(suppl 16) S93-94, 2012

135. AMINOFF MJ, Christine CW, Wong PYA, Husted KH, Liu S, Liu V, et al. Identification of kinetic biomarkers in Parkinson’s disease. 16th annual International Movement Disorder Congress, Dublin, Ireland, 2012

136. Tien I, AMINOFF MJ. Using a wireless inertial sensor system to characterize gait abnormalities in Parkinson’s disease. 16th annual International Movement Disorder Congress, Dublin, Ireland, 2012